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Abstract 
The unnatural threo-6-acetoxy-5-hexadecanolide and the natural mosquito 
oviposition pheromone erythro-6-acetoxy-5-hexadecanolide were synthesized in a 
diastereodivergent fashion in 44% and 33% overall yield respectively from 5-
bromovaleric acid and undecanal. The key step utilized a chemoenzymatic epoxidation-
lactonization of a naturally available fatty acid to form the 6-hydroxy-5-hexadecanolide 
core.
17
  
The epoxidation strategy was later adapted to allow for an asymmetric synthesis. 
Shi epoxidation afforded highly enantioenriched (5R, 6R)-6-hydroxyhexadecanolide (er = 
10) in 70 % overall yield. Other derivatives of the chiral ketone catalyst were also 
screened.  
Finally, attempts were made to obtain the correct stereochemistry at C(6) of the 
target with a dynamic kinetic transformation using lipase and a transfer hydrogenation 
catalyst. Epimerization of the lactol with the transfer hydrogenation catalyst was 
successful, but lipase mediated reactions halted at <10 % conversion. 
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1.0 Introduction 
1.1 Background on Mosquito Oviposition Pheromone 
A series of experiments initiated in 1983 by Laurence et al. led to the 
identification of (5R,6S)-6-acetoxy-5-hexadecanolide [(-)-1, Figure 1] as the major 
chemical component contained within the apical droplets found on egg rafts of Culex sp. 
mosquitos and also responsible for the potent and selective attraction of gravid Culex 
mosquitos.
1 
Synthetic Mosquito Oviposition Pheromone (MOP, (-)-1) was found to 
produce a significant dose dependant attractive response, similar to that of egg rafts,
1a
  in 
Culex sp. to oviposit (i.e., lay eggs) relative to a control.
1c, e
  The examined mosquitos did 
not exhibit a significant response in oviposition attraction to the (5S, 6R) enantiomer (+)-
1 when compared to a control.
1c, e  
The two threo enantiomers (5S, 6S) (+)-2 and (5R, 6R) 
(-)-2 also did not show any significant response to oviposition attraction compared to a 
control.
1c, e
 This suggested that the active site interactions occur at the lactone portion of 
the molecule and were stereoselective at the 5,6-diester portion of the molecule. 
Alteration of the length of the n-alkyl portion of the molecule resulted in a loss of 
biological activity.
2
 More recently it was discovered that the biological response was 
mediated by an odorant binding protein found in Culex antennae.
3a
 It was demonstrated 
that binding occurred through a hydrophobic pocket that could accommodate alkyl chains 
of all four isomers and hydrogen binding interactions with the chiral hydroxylactone 
portion of the molecule.
3b
 Aedis sp. and Anophelis sp. mosquitoes did not show a 
significant response to oviposition attraction, suggesting that the pheromone was genus 
specific.
6 
12 
 
 
Figure 1. Four Stereoisomers of 6-Acetoxy-5-Hexadecanolide 
Culex sp. mosquitoes are vectors for a number of avian and mammalian diseases.
4
 
Malaria and the West Nile (WN) virus are affecting the agricultural industry and human 
health significantly in parts of Africa, Asia, Europe and South America.
4
 WN virus is a 
flavivirus disease native to Africa, Asia and Europe that is transmitted in natural cycles 
between mosquitos and birds but has been known to affect humans and livestock.
4, 5
 WN 
virus was isolated from North American birds as well as Culex sp. and Aedus sp. 
mosquitoes in 1999.
4b
 The Culex pipiens species complex is the predominant vector for 
WN virus in Europe and North America.
4
 Culex pipiens pipiens biotype feeds primarily 
on birds (i.e., ornithophilous), breeds in rural open-air collections of water (i.e., 
epigeous), requires blood to produce its first batch of eggs (i.e., anautogamous), is unable 
to breed in confined spaces (i.e., eurygamous) and able to hibernate through the winter 
(i.e., heterodynamous).
4c
 In contrast, the Culex pipiens molestus biotype is 
mammophilous, autogamous, stenogamous and homodynamous.
4c
 The Culex 
quinquefasciatus species is also a vector for WN virus and shares some common traits 
with the Culex pipiens molestus biotype (i.e, stenogamous and homodynamous) and has 
no preference for birds or mammals, but is found primarily in tropical climates.
4c
 The 
13 
 
Culex genus is the primary vector responsible for the spread of WN virus world-wide, 
and contributes to the spread of other encephalitic diseases as well as parasites.
4, 5
 
National and international health organizations have implemented programs to monitor 
the spread of WN virus since its emergence and steady growth of occurrence in Europe 
and North America.
4a
 Although surveillance of mosquito populations is the most accurate 
means for assessing risk in a given area, sampling mosquito populations remains costly 
due to the reliance on CO2 based traps.
4
 In order to monitor these diseases, (-)-1 has 
become a sought-after attractant for the surveillance of mosquito populations for 
arboviruses, due to its selectivity for gravid mosquitos (i.e., those carrying fertile eggs) 
that have had a chance to become laterally infected by taking in blood.
6
  
Apart from its use in mosquito surveillance, (-)-1 has also been used in 
conjunction with larvacides as an alternative method of pest control.
7
 Generally, chiral 
alkanolides with exocyclic hydroxyl groups are structurally similar to MOP and are 
gaining importance due to their application as chiral building blocks and their presence 
within various important natural products.
8d  
1.2 Previous Syntheses 
The existing demand for the natural product has generated over twenty total 
syntheses of (-)-1 and its corresponding stereoisomers since Mori’s total synthesis in 
1983.
8, 9, 10, 11, 12a, c
 These previous syntheses of 6-acetoxyhexadecan-5-olides have 
generally revolved around two principal steps: the creation of the requisite carbon 
skeleton through carbon-carbon coupling reactions and creation of the two chiral centres 
using chiral pool reagents,
8b, g, h, i, k
 Sharpless epoxidation,
1c, 8a, f, j, l, n
 asymmetric 
dihydroxylation,
8d, e
 and use of chiral auxiliaries.
8m
 Noteably, chiral induction and carbon 
14 
 
framework assembly were combined in a different strategy using asymmetric aldol 
addition.
10, 11
 Among these, brief total syntheses (under 7 steps) of enantioenriched 
pheromone are much more rare.
10, 8e
 
Although enantiomerically pure material was obtained, chiral pool syntheses were 
often expensive, involving alteration of functionalities in natural products to isolate the 
requisite chiral centres in the molecule and create reactive sites for coupling reactions to 
yield the requisite number of carbon atoms. Chiral pool sources have ranged from 
ascorbic acid,
8g
 tartrate,
8b, h
 furfuryl alchohols,
8i
 and 2-deoxyribose.
8k
 Syntheses 
employed sources of pure enantiomers which were then altered to suit the desired 
synthetic pathway required to incorporate the chiral source. Notably, Gravier-Pelletier et 
al. employed this strategy by converting D-isoascorbic acid to epoxybutanediol acetonide 
3 then proceeding through a nucleophilic alkylative epoxide opening, protection, 
deprotection, Mitsunobu epoxidation and alkylation sequence to construct the carbon 
framework with chirality in place (Scheme 1).
8g
  
 
Scheme 1. Enantiopure Synthesis from D- or L-Isoascorbic Acid Derivatives 
15 
 
Subsequent hydrogenation to reduce the internal alkyne and debenzylate at C(6) followed 
by transesterfication and acetylation yield the MOP (-)-1. The (5S, 6S) (+)-2 and (5S, 6R) 
(-)-1 stereoisomers were also synthesized by this method by alternating the order of 
nucleophilic additions to 3 or its epimer 11 (Scheme 2). The above synthesis offers the 
first example of full characterization of enantiopure forms of each MOP stereoisomer 
arrived at using a divergent approach. 
 
Scheme 2. Divergence by Modulating Alkyl Addition 
A similar approach was taken by Kotsuki et al. using tartaric acid derivatives by 
performing a one pot double alkylation to assemble the carbon skeleton (Scheme 3).
8h
 A 
sequence comprising of ozonolysis, oxidation of the aldehyde with AgNO3, deprotection, 
and acetylation afforded the key (5R, 6R)-hydroxylactone (-)-20, which upon mesylation 
and acetylation with cesium acetate afforded enantiopure (-)-1. 
16 
 
 
Scheme 3. Enantiopure MOP Synthesis from a Tartaric Acid Derivative via One-Pot 
Dialkylation 
 
More recently, a similar approach was taken where ring closing metathesis 
(RCM) was used to construct the cyclic portion of the carbon skeleton, starting with a 
bis-Weinreb amide (21) derived from L-tartaric acid to synthesize MOP in eight steps and 
31 % overall yield (Scheme 4).
8b
 This approach required the same number of steps to 
complete as Kotsuki’s methodology, however two equivalents of 23 were obtained from 
the starting amide 21 and the use of RCM allowed for an unusual cyclization through 
carbon-carbon bond formation. Notably, Mitsunobu esterification conditions were used to 
correct for the relative stereochemistry in this case. 
17 
 
 
Scheme 4. Synthesis of MOP from Chiral Weinreb Amide using Olefin Metathesis 
 Asymmetric catalytic methods are advantageous over chiral pool syntheses as 
they do not rely on stoichiometric amounts of readily available chiral building blocks and 
instead transfer chirality catalytically to prochiral building blocks. Sharpless asymmetric 
epoxidation is one asymmetric catalytic strategy that has been employed successfully to 
introduce chirality in the synthesis of the 6-acetoxyhexadecan-5-olides.
1c, 8a, f, j, l, n
 It 
generally involves the use of titanium(IV)tetraisopropoxide and an ester of either D- or L-
tartrate. The two form a dititanium complex with the coordinated tartrate ester imparting 
asymmetry on the catalyst (Figure 2).
13
  
18 
 
 
Figure 2. Sharpless Chiral Dimeric Titanium Complex 
The catalyst is activated by coordination of tert-butyl hydroperoxide and subsequent 
coordination of the allyl alcohol positions the double bond in a spiro-transition state with 
the coordinated peroxide (Figure 3).
21
  
 
Figure 3. Putative Sharpless Epoxidation Transition State Assembly 
Sharpless asymmetric epoxidations are therefore inherently limited to allyl alcohols in 
substrate scope in order to achieve enantioselectivity. Generally, cis-olefins tend to react 
slower than trans-olefins.
13
 Apart from these requirements in substrates, Sharpless 
19 
 
epoxidation is a powerful tool for the synthesis of highly enantioenriched epoxyalcohols 
and resolution of racemic allyl alcohols to create up to three contiguous chiral centers. 
Sharpless epoxidation has been employed in the synthesis of MOP either to 
resolve secondary alcohols (Scheme 5a),
8a, f, j, l
 or epoxidize primary allyl alcohols 
(Scheme 5b).
8n
 
 
Scheme 5. Strategies for MOP synthesis using Sharpless Epoxidation 
In the former case, the chiral secondary epoxyalcohol products of resolution (30 and 31) 
were subjected to nucleophilic epoxide opening to produce the erythro-relative 
stereochemistry with the alcohol oxygen of the starting material on C(6) of the product 
and the epoxide oxygen on C(5). Epoxide opening proceeded through nucleophilic 
alkylation (Scheme 6a),
1c, 8l
or simply through nucleophilic opening with iodide once the 
carbon framework was in place (Scheme 6b).
8f
 A third strategy, involved the resolution of 
a cyclic olefin, 43, followed by subsequent monoxidation of the unepoxidized olefin, 44a, 
then Bayer-Villiger oxidation/deprotection and acetylation to afford MOP (-)-1 and the 
corresponding (5S, 6S)-diastereomer (+)-2 (Scheme 6c).
8j
  
20 
 
 
Scheme 6. Different Approaches to MOP Synthesis using Sharpless 
Epoxidation/Kinetic Resolution 
The second strategy, involving the epoxidation of primary allyl alcohols was utilized by 
Lin et al. to produce a stereodivergent synthesis of all four MOP stereoisomers (Scheme 
7).
8n
  
21 
 
 
Scheme 7. Stereodivergent Synthesis via Sharpless Epoxidation 
This approach is entirely divergent, allowing for the synthesis of any desired stereoisomer 
of MOP from a single starting material. Epoxidation of the primary allyl alcohol has the 
advantage of theoretically converting the entire starting mass to the desired product, 
unlike the resolution methods that are limited to 50 % theoretical conversion. However, 
although the allyl alcohol is required for epoxidation, a series of synthetic steps must be 
introduced to subsequently obtain the carboxyl terminus of the carbon skeleton. 
Asymmetric dihydroxylations on disubstituted alkenes, followed by regiospecific 
hydroxyl inversion have been successful strategies towards the synthesis of 6-
acetoxyhexadecan-5-olides (Scheme 8).
8d, e
 Standard Sharpless asymmetric 
dihydroxylation conditions were employed using AD- (commercially available mixture 
of K2OsO2(OH)4, K3Fe(CN)6, K2CO3, Hydroquinine 1,4-phthalazinediyl diether). 
22 
 
Syntheses involved asymmetric dihydroxylation of a 5-hexadecanoic acid derivative or 
precursor (54 or 58, Scheme 8), followed by protection of the vicinal diol and subsequent 
formation of the free carboxylic acid followed by concomitant lactonization-deprotection 
of the diol.  
 
Scheme 8. Two Approaches to MOP Synthesis Using Asymmetric Dihydroxylation 
Both syntheses were conceptually similar in their overall design, affording the target (-)-1 
in eight synthetic steps (Scheme 8). As a diol protecting group, N’,N’-
carbonyldiimidazole (CDI) was the superior reagent (Scheme 8a), allowing for the 
isolation of (-)-1 in 22 % overall yield from 54. Carbonate could be obtained in much 
higher yield than the analogous cyclic sulfite formed using thionyl chloride (Scheme 8b), 
resulting in a relatively lower overall yield of (-)-1 (9 % from 58). Furthermore, the 
cyclization step to form lactone (-)-10 was much more effective, employing a 
concomitant oxidation/cyclization to obtain the key intermediate in high yield. In 
23 
 
contrast, the two step methyl ester hydrolysis/substitution using LiOH, followed by 
treatment of the resulting sulfate salt with catalytic sulfuric acid to hydrolyse the sulfate 
ester resulted in a lower yield of lactone (-)-1. It seems likely that elimination by-products 
of the intermediary sulfate ester would form under the harsh basic conditions used for 
methyl ester hydrolysis. Nevertheless, the fatty acid methyl ester appeared to be a slightly 
better substrate for dihydroxylation and represented an advanced intermediate with a 
potential biological source, however hydrolysis of the methyl ester would not be 
favourable in later stages of the synthesis (i.e., after oxidation of the olefin). 
The fatty acid derivative was arrived at by a Wittig reaction starting from 
valerolactone derivatives 63 or 64, with undecyl triphenyl phosphonium bromide 
(Scheme 9).
8d, e
 
 
Scheme 9. (E)-Selective Fatty Acid Synthesis 
The Wittig reaction was controlled using the Schlosser modification to favour the E-
isomer,
8d
 or the favoured Z-olefin from a conventional Wittig reaction was isomerized to 
obtain the E-isomer.
8e
 The use of sec-BuLi base allowed for the formation of the more 
stable lithiumbetaine, which underwent a subsequent isomerization to the 
24 
 
thermodynamically more stable trans-betaine and subsequent formation of 
oxaphosphetane and collapse to the E-olefin, 54, with aqueous workup in the presence of 
potassium salts. Conversely, a standard Wittig reaction under kinetic conditions and 
sodium salts was employed to yield the Z-olefin, 66, followed by radical isomerization 
using thiophenol and azobisisobutyronitrile (AIBN) to obtain the E-isomer 54.
8e
 
Chiral auxiliaries have been used to induce chirality through steric control of a 
hydride reduction of a ketone 67 to yield chiral alcohols 68 or 69 (Scheme 10).
8m
 The 
DIBAL-H reduction proceeds in accordance with a Felkin-Anh model to give the (R)-
carbinol 69. The L-Selectride (LiBH(sec-Bu)3) reduction with LiI proceeded in 
accordance to Cram’s chelate rule to give the (S)-carbinol 68. Removal of the chiral 
auxiliary yielded an -hydroxy aldehyde. The second chiral centre was created through a 
stereoselective Grignard addition. Addition with alkyl magnesium bromide in ether was 
selective for the Cram product with 80% d.e. The anti-Cram product of the (R)--
hydroxy aldehyde provided the route to the correct stereochemistry for (-)-1. 
 
Scheme 10. Chiral Auxiliary Used to Impart Facial Selectivity 
25 
 
 Most recently, asymmetric organic catalysis was shown to be an effective approach to all 
four 6-acetoxyhexadecan-5-olide stereoisomers as well as other chiral lactones with 
substituted -hydroxyls.10, 11 Sun et al. first showed that proline-catalyzed aldol additions 
to cyclopentanone followed by Baeyer-Villiger oxidation with m-CPBA to form the -
lactone are an effective and concise route to 6-hydroxy-hexadecan-5-olide stereoisomers 
(Scheme 11).
10
 
 
Scheme 11. Synthesis of Enantioenriched Hydroxylactone Intermediate using a L-
Proline Catalyzed Aldol Addition 
Proline-catalyzed asymmetric aldol additions proceeded through an enamine 
intermediate derived from a symmetric ketone.
14
 The carboxylic acid of the proline 
portion of the intermediate directs the facial approach of the incoming aldehyde.
14, 15
 The 
absolute geometry of the aldol product is determined by the hydrogen bonding 
interactions of the aldehyde oxygen with the proline carboxylic acid.
14 
The presence of 
water(~500 mol % H2O) was demonstrated to invert the diastereochemical outcome of 
the reaction with respect to anhydrous conditions.
11
  The major by-product occured 
through the transition state with the syn-enamine.
15
 The Baeyer-Villiger reaction 
proceeded through a tetrahedral intermediate following nucleophilic attack of the peracid 
on the carbonyl carbon of ketone 71.
16
 The tetrahedral intermediate underwent a 1,3-α-
carbon migration at the most electron rich carbon while retaining its stereochemistry.
16
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1.3 Racemic Synthesis
17
 
Upon closer assessment of previous syntheses, it became apparent that 
hydroxylactone (-)-10 or the corresponding (5R,6R)-diastereomer (-)-20 occurred as key 
synthetic intermediates in many previous syntheses (see Schemes 1, 3, 6b, 7, 8, 10, 11 
and related references), through which the target (-)-1 was obtained, often in one step 
(Scheme 12). Furthermore, the hydroxylactone skeleton was most directly accessed by 
oxidation of some derivative of fatty acid 72. 
 
Scheme 12. Retrosynthetic Analysis Based on Previous Syntheses 
Although the various enantioselective syntheses have allowed for the elucidation of the 
specific biological activities of each stereoisomer, these methods have been of limited 
practicality for large scale production of optically enriched 1 for control or surveillance 
applications. Notwithstanding, biological activity assays indicated that the non-natural 
stereoisomers were inactive, but not repulsive,
1c, e
 allowing for the use of racemic 
mixtures ()-1 as attractants in oviposition traps.12 Importantly, it has been shown that 
bioactive plant oil mixtures containing racemic ()-1 were produced from Kochia 
scoparia seed extract that contained ~25 % (Z)-5-hexadecenoic acid, thus offering a 
renewable source for the production of oviposition attractant.
12a, b
 Furthermore, rare 
naturally derived fatty acids are becoming increasingly available through modern 
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bioproduction technologies. Biosynthetic methods for the synthesis of 72 from palmitic 
acid, mediated by a desaturase enzyme in mutant E. coli strains have recently been 
reported,
18
 while different mutant strains of yeast or E. coli have been used to produce 
various unsaturated fatty acids in industry.
19
 
The most successful strategies for the synthesis of racemate (±)-1 have involved 
either aldol addition of cyclopentanone to undecylaldehyde followed by Bayer-Villiger 
oxidation and acetylation (Route A, Scheme 13),
9
 or dihydroxylation of (Z)-5-
hexadecenoic acid (72) or the methyl ester of 72 followed by intramolecular cyclization 
to form the erythro-hydroxyalkanolide precursor to (±)-1 (Route B, Scheme 13).
12a, c 
 
Scheme 13. Effective Racemic Strategies 
Both strategies lead to a concise synthesis of racemic erythro-6-acetoxy-5-
hexadecanolide [(±)-1] with high overall yields (~ 65 %). Utilizing route B, product (±)-1 
was obtained from the naturally available acid 72 via the dihydroxylation route; 
unfortunately this transformation required the use of stoichiometric heavy metal reagents.  
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Alternatively, route A was recently employed to access enantioenriched (-)-1 and (-)-2 
using the Hajos-Parish asymmetric aldol reaction;
10, 11
 however, the large excess of m-
CPBA (~ 5 eq) for Bayer-Villiger oxidation detracted from this procedure.  Apart from 
the hazardous reagents required for these oxidations, the necessity for purification by 
column chromatography at each step of the synthesis greatly limited the scalability of 
these reactions.  
 To overcome the limitations associated with the above oxidations and at the same 
time incorporate salient features of routes A and B in Scheme 13, it was reasoned that a 
more ideal synthesis would intersect with a naturally available acid 72 intermediate and 
proceed through a benign, metal-free oxidation. Epoxidations of olefins, mediated by the 
in situ lipase catalyzed generation of peroxyacids using aqueous hydrogen peroxide as a 
primary oxidant have been reported in the literature and would offer one means to this 
end.
20
 It was also understood that this very mild oxidation procedure would yield the 
hydroxylactone ()-20, after which the relative geometry at C(6) could be inverted by 
esterification to afford (±)-1 (Scheme 14).   
 
Scheme 14. Racemic Retrosynthetic Analysis 
Accordingly, the total synthesis of racemate (±)-1 via an environmentally benign lipase 
mediated epoxidation of (Z)-5-hexadecenoic acid 72 is reported in the first section of this 
work (Scheme 15).  
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Scheme 15. Chemoenzymatic Epoxidation/Lactonization 
Marked features of this synthesis include the minimization of column purification by 
using urea inclusion crystallization and favourable ‘Green’ metrics. 
1.4 Asymmetric Synthesis using Shi Epoxidation 
Having established a sound racemic synthesis, catalytic methods for the chiral 
epoxidation of fatty acid 72 were explored. Nevertheless, the lack of functionality near 
the alkene made 72 a difficult substrate for chiral oxidation. Although some success had 
been reported with Sharpless asymmetric dihydroxylation of methyl esters of 72, 
reactions had to be stopped at low conversions (60-70 %) and required a difficult 
cyclization procedure to obtain the correct diastereomer.
8d, e
 Previous syntheses 
employing chiral epoxidation relied on earlier introduction of chirality, followed by 
carbon-carbon bond formation to obtain the requisite carbon skeleton, at the cost of extra 
synthetic manipulations (vide supra). To avoid the introduction of additional synthetic 
steps, and as an extension of the initial strategy to proceed through fatty acid intermediate 
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72, the direct asymmetric epoxidation of this unfunctionalized alkene was then 
investigated. 
The most widely used methods for olefin epoxidation have generally relied on the 
presence of so-called “handles” near the alkene to transfer asymmetry from the catalyst to 
the substrate. The most common substrates for alkene epoxidation have therefore been 
allyl alcohols as in Sharpless epoxidation,
13
 and aryl substituted alkenes as in Jacobsen 
epoxidation.
21
 Both of the above techniques rely on the oxidation of a transition metal 
center (i.e., Ti, W, Mo, Mn) by a primary oxidant and creation of a bias for the transition 
state assembly leading to the favoured stereochemistry of the epoxide using a chiral 
ligand.  
Methods for asymmetric epoxidation of unfunctionalized olefins have been 
limited to date.
22
 Apart from biocatalytic approaches utilizing chloroperoxidase 
enzymes,
23
 or P450 monooxygenases in whole-cell fermentations,
24
 organocatalytic 
epoxidation techniques have had moderate to high success in terms of yield and 
enantioselectivity for unfunctionalized olefins, such as monounsaturated fatty acids.
25
 
Asymmetric organocatalytic approaches have relied primarily on the use of chiral organic 
acids in the presence of primary oxidants, or dioxiranes generated in situ from chiral 
ketones.
25
 The latter have had generally more success with regard to enantioselectivity. 
However more recently, more sophisticated chiral organic acid catalysts such as 81 have 
been used in conjunction with lipase and hydrogen peroxide to generate a chiral peroxy-
acid in situ, leading to modest enantioselectivities for various phenyl-substituted styrenes 
(Figure 4).
27
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Figure 4. Organic Auxiliaries and Catalysts for Asymmetric Epoxidation of Olefins 
Nevertheless, early iterations of chiral ketone catalysts struggled with low selectivities (5-
20 % ee) and required near stoichiometric catalyst loadings.
28, 29
 These problems were 
found to arise from two sources, the epimerization of -carbonyl carbons leading to 
erosion of enantioselectivity, and the competitive Bayer-Villiger oxidation of ketones to 
esters leading to degradation of the catalyst.  Over the years increasingly sophisticated 
catalyst designs have managed to overcome epimerization problems by incorporating 
chiral -quaternary carbons into the structure of the catalyst, or by employing axially 
chiral backbones (i.e., BINOL), although the latter approaches have been less 
successful.
29
 The competitive Bayer-Villiger oxidation products can be partially limited 
through careful control of reaction conditions to favour the dioxirane product (vide infra). 
 Between 1996 and 2006, Shi and coworkers reported a variety of carbohydrate 
derived chiral ketone catalysts with chiral -spiro functionalities and success with the 
epoxidation of olefins with various substitutions and functionalities (Figure 5).
29b-d
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Figure 5. Classes of Shi’s Catalysts and Examples of Common Derivatives 
Impressive enantioselectivities were observed for a variety of trans- and trisubstituted 
olefins using ketone 82, which features a quaternary spiroketal functionality at the -
position and a fused ketal blocking the bottom face of the main ring (Entries 1-8, Table 
1).
30, 31
 
Table 1. Asymmetric Epoxidation of Olefins using Shi’s Ketone Catalysts 
Entry Catalyst Loading Substrate 
Yield 
(%) 
ee 
(%) 
Absolute 
Configuration 
1 82 0.3  75 93 (+)-R,R 
2 82 0.2 
 
88 93 (+)-R,R 
3 82 0.3 
 
76 91 (+)-R,R 
4 82 0.3 
 
92 92 (+)-R,R 
5 82 0.3 
 
66 94 (+)-R 
6 82 0.3 
 
94 89 (+)-R 
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7 82 0.3 
 
91 84 (+)-R,R 
8 82 0.3 
 
41 97 (+)-R,R 
9 82 0.3 
 
92 12 (+)-R,R 
10 82 0.3 
 
43 61 (+)-R,R 
11 82 0.3  90 24 (-)-R 
12 83b 0.1 
 
78 68 (+)-R,R 
13 83b 0.05  90 65 (-)-R 
14 84a 0.3 
 
61 97 (+)-R,R 
15 84a 0.15  92 81 (-)-R 
16 84d 0.25 
 
52 64 - 
17 84d 0.25 
 
89 82 - 
18 84d 0.25 
 
75 91 RR-lactone 
19 84d 0.25 
 
85 86 RR-lactone 
 
Initially stoichiometric quantities of ketone 82 were required to maintain high 
enantioselectivity due to the degradation of catalyst via the competitive Bayer-Villiger 
oxidation of the ketone.
31
 Upon careful screening of solvent, pH and temperature 
parameters, it was found that the competitive oxidation pathways can be disfavoured at 
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high pH and low temperature and polar aprotic solvents, thereby reducing catalyst 
loading to 20-30 mol %.
31, 32
 The catalyst was later found to effectively mediate the 
epoxidation of silylenol ethers, esters, conjugated enynes and conjugated dienes with 
moderate to high enantio-, chemo- and regioselectivity.
33
 While high enantioselectivities 
were obtained with disubstituted trans and trisubstituted alkenes, cis and terminal alkenes 
were converted with high yield but low enantioselectivites in reactions catalyzed by 
ketone 82 (Entries 9-11, Table 1).
31
 
 A series of second generation pseudo-C2 symmetric catalysts 83a-e, derived from 
(-)-quinic acid, were later developed, moreover 83b was found to provide improved 
enantioselectivities with cis-disubstituted and terminal olefins (Entries 12 and 13, Table 
1).
34
 Although some success was had with this class of catalyst, the lengthy synthesis (9-
10 steps) detracted from this approach. The initial success of the pseudo-C2 symmetric 
catalysts initiated a series of studies focused on probing the catalyst structure with an aim 
to develop an effective catalyst for the epoxidation of cis and terminal olefins.
34b, 35
  
With no further success on variants of the two previous motifs, spiro or fused 
acetonide rings were replaced with N-substituted oxazolidinones, of which class 84 had 
significant success with the epoxidation of a variety of cis-disubstituted and terminal 
olefins (Entries 14-19, Table 1).
36
 Notably, Shi and coworkers, in their recent work, were 
able to epoxidize a C12 fatty acid (yield = 78 %, ee = 88 %) using a derivative of their 
chiral ketone epoxidation catalyst 84d (Entry 19, Table 1).
37
 Epoxidation of hydroxyalkyl 
and methyl substituted olefins resulted in lower enantioselectivity (Entry 16 and 17, 
Table 1), while increasing alkyl chain length (R = Me, Et, n-Bu) led to increased 
enantioselectivity.
37c
 The authors proposed that stereoinduction was governed by 
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hydrophobic interaction of the substrate alkyl chain with the para-substituted anilino 
portion of the catalyst and aqueous solvation of the substrate carboxylate in TS1, based 
on the observed selectivity trends and previous theoretical work on dioxirane olefin 
epoxidation (Figure 6).
38
 
 
Figure 6. Shi's Epoxidation Catalysts and Proposed Competing Spiro-Transition 
States 
The synthesis of (-)-1 was attempted by means of chiral epoxidation of 72, to investigate 
this mode of stereoinduction while providing an example of a four step, asymmetric 
synthesis of MOP that intersects fatty acid 72. 
1.5 Dynamic Kinetic Transformation Experiments 
Although asymmetric epoxidation afforded the hydroxylactone skeleton in fairly 
high optical purity, the problems associated with esterification and epimerization of C(6) 
remained unaddressed. It was known that the resolution of racemic mixtures of erythro-
hydroxylactone ()-10 using immobilized Candida antarctica lipase A(CALA) and vinyl 
acetate in anhydrous media to yield MOP in high enantiopurity had been reported 
(Scheme 16).
39
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Scheme 16. Kinetic Resolution of erythro-Hydroxylactone ((±)-10) 
This work provided the preliminary evidence of selectivity for the target stereoisomer 
using CALA, however the relative stereochemistry of the (5R,6R)-hydroxylactone (±)-20 
would have to be adjusted for a lipase-mediated approach to be feasible in this system. It 
was also known that Bäckvall and coworkers had demonstrated that the dynamic kinetic 
resolution of secondary alcohols could be accomplished by incorporating a process by 
which the alcohol was racemized, namely the in situ oxidation-reduction mediated by a 
dimeric ruthenium catalyst, to achieve full conversion of the starting racemic alcohol.
40
  
The synthesis of the dimeric ruthenium complex and the reductive and oxidative 
properties of the basic and acid monomers formed in solution were first reported by Shvo 
and coworkers.
41
 The complex was demonstrated to be an effective redox catalyst for the 
oxidation of amines and secondary alcohols or reduction of ketones and imines (Scheme 
17).
42
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Scheme 17. Shvo’s Diruthenium Complex as a Redox Catalyst 
A series of enantioenriched esters were synthesized from racemic secondary alcohols 
using Shvo’s catalyst 85, C. antarctica lipase B (CALB), and p-chlorophenyl acetate 
(PCPA) as an acyl donor (Table 2).
40 
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Table 2. Backvall’s Dynamic Kinetic Resolution of Secondary Alcohols 
 
Entry Alcohol 
Yield of Acetate 
(%) 
ee (%) 
1 
 
80 99 
2 
 
77 99 
3 
 
80 97 
4 
 
88 99 
5 
 
68 79 
 
All alkyl and aryl substituted secondary alcohols with large differences in steric bulk 
between substituents were resolved with high yield and optical purity except for the - 
chloroalcohol (entry 5, Table 2). The reduced yield and enantiopurity are likely a result of 
39 
 
increased steric crowding of the alcohol, making it a poor nucleophile for the dissociation 
of the acyl-lipase complex. This steric effect appears from this example to be forgiving, 
as modest yield and optical purity were obtained nonetheless. Subsequently, monomeric 
forms of the catalyst were developed (86, Figure 7), allowing for reactions to be 
conducted at room temperature using tBuOK (5 mol %) as an activator, since heat 
activated dissociation was not required in this case.
43
 
 
Figure 7. Monomeric Ruthenium Catalyst 
The lower temperature allowed for reduced lipase loadings (3 mg/mmol), which degraded 
slowly at elevated temperatures. Although CALA was selective for (-)-10 in a resolution 
of syn-hydroxylactones ()-10, there was no evidence concerning the selectivity between 
the acetylation of (5R, 6R)-(-)-20 and (5R, 6S)-(-)-10 alcohols. The transformation of (-)-
20 to MOP [(-)-1] using Shvo’s catalyst and immobilized lipases [i.e., Novozyme 435 
(N435, CALB) and Immobead 150 (CALA or CALB)] was therefore investigated in this 
work (Scheme 18).  
40 
 
 
Scheme 18. Dynamic Kinetic Transformation Strategy for Enantioenriched (5R, 
6R)-Hydroxylactone ((-)-20) 
The epimerization of the C(5) center was a concern, but it was thought that under the 
anhydrous conditions, the relative rate of hydrolysis and intramolecular lactonization 
should be too slow to allow for the accumulation of long-lived lactone-open forms of (-)-
20. Similarly, the acetylation of the C(5) position was of little concern as the 
intramolecular re-lactonization was more likely to be preferred.  
Furthermore, with evidence for the dynamic asymmetric transformation of a 
racemic mixture of 1,3-diol enantiomers and diastereomers to form a single enantiomer of 
the diacetate using a modification of Bäckvall’s procedure for secondary alcohols,44 the 
transformation of the racemic anti-hydroxylactone ()-20 was also investigated. 
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Although 1,3-acyl migration would occur in the 1,3-system,
44
 it was reasoned that the 
1,2-monoester diol ()-20 would not be able to undergo such a transformation. This 
approach would be the most favorable if successful, as the costly synthesis of the 
asymmetric organocatalysts 84b-d could be avoided and may provide an asymmetric 
route to each of the four stereoisomers of MOP simultaneously (Scheme 19). 
 
Scheme 19. Dynamic Kinetic Transformation Strategy for Racemic threo-
Hydroxylactone (()-20) 
 
42 
 
2.0 Results and Discussion 
 
2.1 Synthesis of Racemate
17
 
At the outset, fatty acid 72 was synthesized by Wittig olefination under kinetic 
conditions to favour the (Z)-isomer (Scheme 20), as determined by characteristic signals 
from 
1
H and 
13
C NMR.
45
 Although Wittig olefination cannot be considered green, the 
reaction was chosen as a facile route to pure 5-hexadecenoic acid 72, as a proof of 
principle for the synthesis of (±)-1 from the naturally available fatty acid.
  
 
Scheme 20. Synthesis of Fatty Acid Intermediate 
While investigating choice of base, it was found that the use of sodium t-amyloxide (t-
AmONa), in a similar manner to that described by Dauben et al.,
46
 resulted in higher 
yields and cleaner workup than analogous reactions with potassium t-butoxide in THF 
(see Appendix A1.1 for a detailed experimental procedure)(Table 3). 
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Table 3. Choice of Base and Purification Technique in Wittig Olefination  
Entry Base Solvent 
Urea Yield 
(%)
(a)
 
Column Yield 
(%)
(b)
 
Z:E
(c)
 
1 t-BuOK THF 32 45 8:2 
2 t-AmONa 
THF: toluene 
(1:1) 
74 - 8:2 
(a) Yield of reactions purified using two serial urea inclusion crystallizations at 5 g scale. (b) 
Yields of reactions purified by column chromatography at 100 mg scale. (c) Ratios were 
estimated using 
1
H NMR.
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Purification methods for the removal of triphenylphosphine oxide (TPPO) were 
then investigated. The majority of TPPO remained in the organic reaction medium, 
however ~25 % of TPPO was carried over in the acid/base extraction resulting in a 
significant TPPO impurity in the crude oil extract. The use of column purification proved 
challenging, requiring a gradient mobile phase starting with hexanes, then hexanes-ethyl 
acetate (1:1), to produce colourless fatty acid in 61 % yield at a maximum 100 mg scale. 
To overcome difficulties with large scale column purification, the gram scale (1 – 5 g) 
purification of extract was achieved using urea inclusion crystallization.
47
 The urea 
purification process involved the crystallization of urea in a solution of fatty acid in 
methanol. The fatty acid was retained in the solid urea while impurities remained in the 
solution. The solid urea was collected by filtration and purified fatty acid was obtained by 
dissolving the crystals in dilute HCl (1 M) and extracting with Et2O. Using the conditions 
outlined by Swern and Parker for the purification of oleic acid from vegetable oil,
47
 the 
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purification of the crude fatty material obtained from acid-base extraction from the Wittig 
reaction mixture was attempted. Under the initial conditions, fatty acid was successfully 
obtained after four purifications with 65 % mass recovery overall (Entry 1, Table 4; 
Figure 8).  
Table 4. Conditions for Purification of Crude Fatty Acid using Urea Crystallization 
Entry 
Mass of 
crude fatty 
acid (g) 
[Urea] 
(M) 
Relative volume 
(ml/g) 
No. Steps 
Mass 
recovery 
(%) 
1 1.0 6.6 9 4 65 
2 1.0 12 9 8 63 
3 1.0 3.3 9 4 48 
4 1.0 6.6 13 2 80 
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Bottom to top: 1H NMR spectra of (1) crude fatty acid material obtained from acid-base 
extraction of Wittig reaction mixture, (2-4) fatty acid material obtained from urea crystallization, 
and (5) the pure fatty acid obtained from a fourth purification step. 
Figure 8. 
1
H NMR Spectra of Fatty Acid Material Obtained from Serial 
Purifications with Urea 
Increasing the concentration of the urea solution resulted in greater recovery but lower 
selectivity for the fatty acid (Entry 2, Table 4), while the inverse effect was observed for 
more dilute solutions (Entry 3, Table 4). Improved conditions were generated by using a 
larger volume of urea solution at the concentration described by Swern and Parker 
relative to the weight of crude oil material. It was found that washing the filter cake 
containing retained fatty acid in urea with hexane resulted in cleaner material without loss 
of recovery. Inclusion crystallization with urea under these conditions allowed for the 
isolation of up to 3 g of clear colourless fatty acid material that was free of TPPO and 
analytically pure in 74 % overall yield and retention of the (Z)-stereochemistry, while 
(1) 
(2) 
(3) 
(4) 
(5) 
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producing only aqueous urea solution and a small volume of TPPO in methanol as waste 
(Entry 4, Table 4). 
With the requisite fatty acid in hand, the lipase-mediated Prilezhaev oxidation of 
the olefin was investigated (Scheme 21). 
 
Scheme 21. One-Pot Lipase Mediated Prylazhaev Epoxidation/Cyclization 
Initially, the incremental addition of hydrogen peroxide to a 100 mM solution of fatty 
acid 72 in cyclohexane over immobilized lipase resulted in a poor combined yield (30 %) 
of hydroxylactone and epoxyacid (Entry 1, Table 5). Previously, it was reported that the 
epoxyacid 77 undergoes oxidation to the peracid at a much slower rate than the 
unsaturated acid 72, while the formation of peracid is much faster than the epoxidation.
20a
 
Accordingly, it was reasoned that an incremental addition of the fatty acid would 
maintain higher concentrations of the unsaturated fatty acid 72 during the progress of the 
reaction, which ultimately resulted in complete consumption of fatty acid as observed by 
TLC after 48 hours with minimal formation of by-products (Entry 2, Table 5).The 
epoxidation led to the formation of epoxy acid 77 with ~10 % hydroxylactone ()-20 as 
observed by crude 
1
H NMR. Thereafter, complete lactonization was observed by heating 
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the cyclohexane solution under reflux. Further optimization revealed that the addition of 
0.04 % (v/v) Et3N significantly reduced the time required for lactonization from 72 h to 
12 h, likely due to the base acting as a proton shuttle. The diastereomerically pure threo-
hydroxylactone ()-20 was isolated in 40 % yield by crystallization from hexanes, and 
the remaining hydroxylactone ()-20 was obtained from flash chromatography of the 
mother liquor and subsequent crystallization for a combined yield of 65 %. With these 
working experimental conditions, the ability to reuse the immobilized lipase was 
investigated. It was found that the procedure could be repeated up to three times with no 
apparent loss of activity, so long as reaction runs were repeated immediately after 
filtration (Entry 2-4, Table 5). Storage of the used immobilized lipase for one week at 
7 
o
C resulted in complete loss of activity. Using a different immobilizing product such as 
N435 did not have any significant impact on yield. 
Table 5. Oxidation Conditions and Catalyst Recycling 
Entry 
Addition time 
(h)
(a)
 
Aliquots of 
fatty acid 72 
No. of lipase 
reuses
(c)
 
Yield (%)
(d)
 
1 24 1 0 30 
2 24 4 0 69 
3 24 4 1 68 
4 24 4 2 69 
(a) Aqueous H2O2 (15 M) was added over 24 h via syringe pump. (b) Aliquots of a solution of 72 
(0.21 M) in cyclohexane were added to the reaction in 6 h increments. (c) Fatty acid 72 (1.5 
mmol) was epoxidized over 48 h using the same 126 mg of lipase (CALB Immobead 150) for 
each reuse. (d) Represents yield of hydroxylactone ()-20. 
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The synthesis was completed by way of a late diastereodivergent acetylation 
strategy. To this end, the threo-(±)-2 was synthesized by O-acetylation of (±)-20 using 
standard conditions (Scheme 22, Route A).
11
 Conversely, (±)-1 was synthesized by 
mesylation of the C(6) hydroxyl, followed by substitution of the resulting mesylate with 
acetate (Scheme 5, Route B).
8h 
 
Scheme 22. Diastereodivergent Acetylation Strategy 
At this stage, the reaction metrics of the key oxidation steps and the overall 
synthesis, including several commonly used green metrics,
48
 were estimated for this 
synthesis and compared with two of the more successful racemic syntheses (see 
Appendix A3.0 for raw data used to calculate metrics).
8h, 11
 Considering that current 
‘Green’ metrics fail to account for every possible parameter that influences the 
environmental impact of a process, no one metric can be applied to assess the 
sustainability of a given process. As such, a series of green metrics were estimated, along 
with standard reaction metrics like yield and steps, to compare the presented racemic 
synthesis with successful syntheses from the literature. Two metrics relating to mass 
efficiency were selected; (1) Sheldon’s E-factor was selected as an easy measure of 
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relative waste and (2) Glaxo-Smith-Klein’s (GSK) metric was used to gauge reaction 
mass efficiency (RME). Carbon efficiency (CE) was also calculated to gauge the 
efficiency of the transfer of organic material in this synthesis. The E-Factor and RME 
were calculated for each step of the synthesis by Equations 1 and 2 respectively, where 
msm is the mass of starting materials and mp is the mass products.
48
 
  
      
  
      Equation 1. 
    
  
   
          Equation 2. 
The masses of all consumable starting reagents and catalysts were incorporated, while 
solvents were considered recoverable and aqueous solutions were considered benign, and 
therefore excluded from the calculation. These assumptions were made for the sake of 
comparing syntheses at the bench scale, where solvent choices, quantities and lifecycles 
can be expected to change significantly during scale up to an industrial process. Silica 
and urea were considered recoverable and were not factored into the equation. CE was 
determined according to Equation 3, where np is the moles of product, nsm is the moles of 
each reagent, Csm is the number of carbons of that reagent and Cp is the number of 
carbons in the product. 
   
     
∑       
         Equation 3. 
 The reaction and green metrics of this reaction were then compared with those of 
the previous successful conventional syntheses.
9, 12c
 Analysis of the reaction metrics for 
the key oxidation step (Scheme 21 and Table 5, Entry 4) revealed that the lipase mediated 
reaction was more efficient in terms of mass efficiency despite its lower yield when 
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compared to oxidation with osmium and potassium ferricyanide (Table 6). Although the 
dihydroxylation proceeded with high carbon efficiency, the use of excess inorganic salts 
lowered its RME and increased its E-factor significantly. Meanwhile, Bayer-Villiger 
(BV) oxidation had a greater reaction mass efficiency and E-factor but lower carbon 
efficiency due to the stoichiometric organic reagent. Lipase mediated epoxidation, 
although somewhat lacking in yield and RME with respect to BV oxidation, was more 
carbon efficient than BV oxidation and had a lower E-factor than both. More importantly, 
toxic transition metal reagents or m-CPBA were replaced with aqueous hydrogen 
peroxide in the lipase approach. Although cyclohexane was used as a solvent, it was 
successfully recovered by distillation (~ 95 % recovery), and reused in subsequent 
reaction runs. 
Table 6. Comparison of Oxidation Reaction Metrics 
Metric Dawson et al.
9
 Michaelakis et al.
12c
 This Work 
Yield of (±)-20 82 % 90 % 69 % 
Oxidant m-CPBA K3Fe(CN)6 H2O2 
E-Factor 1.3 15.1 0.4 
RME 44 % 6.2 % 66 % 
CE 55 % 92 % 69 % 
Values reported for this work were calculated from reaction parameters obtained from a 
representative epoxidation reaction, yields for this oxidation were generally reproducible within  
5 %. Values for previous work were calculated from data reported in experimental sections of the 
work in question. 
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Finally, the E-factor for the overall process was determined as a sum of E-Factors at each 
step, while the overall RME and CE was calculated as the product of each RME and CE 
in the linear sequence. The overall synthesis scored lower in comparison to the oxidation 
alone (Table 7). Although the overall synthesis was more mass and carbon efficient than 
that proposed by Michaelakis et al., overall yields were comparable to the other two 
syntheses. The synthesis of Dawson et al. was the most mass and carbon efficient among 
the three. However, the nature of reagents and reaction conditions cannot be accounted 
for by the available green metrics. As such, metrics can only serve to aid in a qualitative 
assessment of the relative sustainability of different processes or reactions when placed 
into the context of what is known about the environmental impact of the different 
reagents used in the respective processes or reactions.  
Table 7. Comparison of Overall Synthesis Metrics 
Metric Dawson et al.
6
 Michaelakis et al.
9c
 This Work 
Yield
(a)
 22 % 23 % 16 % 
Steps 3 5 4 
E-Factor 6 106 9 
RME 5.2 % 0.0020 % 2.1 % 
CE 12 % 0.047 % 3.5 % 
(a) Represents the overall yield of the active (5R,6S)-(-)-1 in a mixture of stereoisomers 
2.2 Shi Epoxidation 
Shi’s catalysts (84b-d) were synthesized using a combination of the two 
published syntheses (Scheme 23).
37a, b
 Recrystallization of 92 from ethanol/ether was 
52 
 
absolutely necessary to obtain even modest yields in subsequent steps.  TEMPO/bleach 
oxidation of 94 consistently resulted in poor conversion (~45 % by recovered starting 
material) and products were difficult to isolate and purify resulting in low overall yields 
of < 25 %. Oxidation using PCC was somewhat more successful with yields ranging 
between 55-57 % obtained quite reproducibly.
37a
  
 
Scheme 23. Synthesis of Shi’s catalysts 
Under Shi epoxidation conditions, the fatty acid 72 was epoxidized and partially 
lactonized, resulting in an approximate 60:40 mixture of epoxide 77 and hydroxylactone 
(-)-20 which were isolated together (Scheme 24). Subsequently, the mixture was heated 
to reflux in cyclohexane to convert residual 77 to lactone (-)-20. Interestingly, no proton 
transfer catalyst (Et3N) was required to aid in the lactonization step when crude reaction 
extract from Shi’s epoxidation was heated in cyclohexane under reflux. Prior purification 
of the epoxidation products by flash chromatography followed by lactonization resulted 
in a similarly slow lactonization requiring a catalytic amount of Et3N to promote 
lactonization. This suggested that Shi’s catalyst or one of its degradation products may 
aid in catalysis of the lactonization step. 
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Scheme 24. Chiral epoxidation and lactonization 
Reactions catalyzed by 84b-d converted olefin to the key lactol intermediate, (-)-20, with 
similar overall yields (65 % - 70 %), however optical activity increased with increasing 
alkyl chain length of the catalyst (Table 8). The enantiomeric ratio was estimated for the 
most optically active product by HPLC analysis of the benzoyl ester of hydroxylactone 
(-)-20 as the ratio of the relative peak areas at 254 nm. 
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Table 8. Yield and Enantioselectivity of Asymmetric Epoxidation/Lactonization 
using Different Epoxidation Catalyst Derivatives 
Entry 
Catalyst 
(Figure 5) 
Yield (%)
(a)
 
[]D (conc. 
g/100ml)
(b)
 
e.r.
(c)
 
Absolute 
Configuration
(d),8g
 
1 84b 65 -6.5(1.01) - (-)-R,R 
2 84c 68 -8.3(1.04) - (-)-R,R 
3 84d 70 -9.3(0.95) 10:1 (-)-R,R 
(a) Represents the isolated yield of (-)-20 and the corresponding enantiomer (+)-20. (b) Optical 
rotation was obtained at 21C, in CHCl3, lit. -10.2 (c = 0.87 g/100ml) in CHCl3.
8g
 (c) 
Enantiomeric ratio was estimated from the benzoyl ester of hydroxyl lactone (-)-20 and 
subsequent analysis by HPLC using 95:5 hexane-isopropanol mobile phase, pumped at 1.5 
ml/minute, using a Chiralpak-OD column, a variable wavelength detector set to 254 nm, and was 
determined as a ratio of relative peak area without standardization. (d) The absolute configuration 
was inferred from the sign of optical rotation, while the relative configuration was inferred from 
comparison of hydroxylactone (-)-20 spectra with those in literature.
8g
 
The results from the catalyst screen are in good agreement with the model 
proposed by Shi et al. for the stereoselectivity observed in reactions catalyzed by ketones 
84b-d.
37c
 It was deduced that hydrophobic interactions between the hydrocarbon tail of 
the catalysts 84b-d and aliphatic tail of the substrate govern stereoinduction as opposed to 
steric repulsion effects between trans-olefins and the spiro-functionality of the diketal 
catalyst 82 that dominate the mechanism of stereoinduction in this class.
29
 The greater the 
length of the hydrocarbon tail of the catalyst the stronger the hydrophobic interaction 
with the catalyst appeared to be, leading to a greater energy bias for the TS1 transition 
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state (Figure 6). It was not difficult to imagine, considering the applicability of the model 
of stereoinduction based on hydrophobic interactions and the apparent amphiphilic nature 
of both substrate and catalyst, that the formation of substrate-catalyst mixed aggregates in 
the biphasic system may play a role in governing the overall stereoinduction of this 
process. Work on probing interaction effects between classes of catalysts and fatty acid 
substrates (i.e., non-linear effects on initial enantioselectivity with respect to catalyst 
concentration and mole fractions of mixtures of catalysts) would be warranted to better 
understand this relatively uncommon form of stereoinduction in the realm of chemical 
catalysis. 
The (-)-2 and (-)-1 diastereomers of MOP were synthesized from the R,R-
hydroxylactone (-)-20 using epoxidation catalyst 84d by the same diastereodivergent 
acetylation strategy employed in the earlier racemic synthesis to afford ()-1 and ()-2  
(Scheme 25).  
 
Scheme 25. Esterifications of Enantioenriched Hydroxylactone ((-)-20) 
Surprisingly, the opposite diastereomer was present in each acetylated product in a ratio 
estimated at 1:10 with respect to the desired diastereomer. The appearance of the second 
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diastereomer was not attributed to a change in the relative geometry of the starting 
lactone, which would be mechanistically improbable given the reaction conditions. It was 
considered more likely that the trace diastereomeric impurity was present in the starting 
hydroxylactone (-)-20, but was not detected by 
1
H NMR of the alcohol because the 
assignment was based on characteristic signals arising from one proton. In the acetylated 
product, the methyl protons of acetates on threo-(-)-2 and erythro-(-)-1 products were 
resolved and produced a much stronger signal arising from three protons on the methyl 
group, thereby allowing for the detection of the trace impurity. For this reason, it can be 
assumed that the enantiomeric ratio determined from the benzoate derivative 95, which 
also contained ~10 % of the corresponding diastereomer by relative peak area, was 
representative of the optical purity of the (-)-1 MOP product. Due to the near identical 
ratio of diastereomers in both the product of direct acetylation and mesylate substitution 
indicate that the substitution reaction proceeded, as expected, via an SN2 mechanism, 
consistent with observations made with racemic acetylations.  
2.3 Catalytic Acylation Experiments using Dynamic Kinetic 
Transformation 
Shvo’s catalyst 85 was synthesized by heating triruthenium dodecacarbonyl 97 
and tetraphenylcyclopentadienone 98 in anhydrous methanol under reflux for 24 h.
49
 The 
air-stable dimer was obtained by filtration as a yellow powder in 39 % yield (Scheme 
26).
49
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Scheme 26. Synthesis of Shvo’s Catalyst 
Although the synthesis of the catalyst was low yielding, the expedience and single-step 
synthesis made this route ideal for maintaining a supply of catalyst for screening reaction 
conditions and initial epimerization studies. With the catalyst in hand, the epimerization 
of threo-hydroxylactone ()-20 was probed to determine if the substrate would epimerize 
and to determine the steady state ratio of diastereomers formed in the presence of the 
ruthenium catalyst 85 (Scheme 27). 
 
Scheme 27. Epimerization of threo-Hydroxylactone (()-20) using Shvo’s Catalyst 
Under the reported conditions the hydroxylactone was successfully epimerized to 
yield a mixture of diastereomers, as confirmed by comparison with an authentic sample 
of erythro-hydroxylactone ()-10 produced using the proline catalyzed aldol/Bayer-
Villiger route.
10
 The ratio of diastereomers was estimated using the relative integrals of 
C(6) protons by 
1
H NMR. Once the successful epimerization using Shvo’s catalyst 85 
was established, the synthesis of the PCPA acyl donor 100 was required to probe the one 
pot dynamic kinetic transformation (DKT) conditions.  This was accomplished using a 
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modified solvent-free acetylation of p-chlorophenol (99) under microwave conditions 
(Scheme 28).
50
 
 
Scheme 28. Synthesis of p-Chlorophenyl Acetate under Microwave Conditions 
To adequately scale up the original procedure (1 mmol scale), a screen of reaction scales 
and concentrations was conducted (Table 9). 
Table 9. Scaling of Microwave Synthesis of PCPA 
Entry 
Phenol (99) 
(mmol) 
Ac2O (ml) Silica (g) Yield (%) 
1
(a)
 1.0 1.0 1.0 87 
2
(a)
 2.0 1.0 1.0 91 
3
(a)
 4.0 1.0 1.0 79 
4
(a)
 8.0 2.0 2.0 61 
5
(b)
 12 6.0 6.0 88 
(a) Starting materials were combined in a 5 ml microwave vial and heated to 135 C for 2 minutes 
then worked up. (b) Starting materials were combined and divided into 6 x 5 ml microwave vials 
and were ran as a sequence for 2 minutes at 135 C then recombined and worked up.  
The results of this screen suggested that optimal yields could be obtained when using 
Ac2O (0.5 ml/mmol 99) and silica (0.5 g/mmol 99), at a scale of 2 mmol of chlorophenol 
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per microwave vial. To produce 10 mmol quantities of PCPA, starting materials were 
combined and divided into 6 x 5 ml microwave vials (Table 9, entry 5), which were 
subject to heating at 135 C for two minutes in sequence, with ~10 minutes for cooling 
between runs. Once the batch was completed, the contents of the vials were combined 
and extracted with hexane, then dried to afford the PCPA ester 100. With a reliable 
source of PCPA, the first trial DKT using an optically enriched alcohol was performed 
(Scheme 29). 
 
 
Scheme 29. Attempted Dynamic Kinetic Transformation of Enantioenriched 
Hydroxylactone 
The initial results were not encouraging, because conversion stopped at ~30 % 
and a by-product was isolated with the product, which furthermore persistently co-eluted 
with the product spot in all normal mobile phases available in the laboratory. The 
1
H 
NMR spectra indicated that some product was present as was ascertained by the 
appearance of the characteristic C(5) and C(6) proton signals. However, it was less clear 
what the diastereomeric preference for the acetylation was, but the chemical shift of the 
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C(6) proton suggested that the threo-diastereomer was the major one. At this point the 
identity of the by-product was completely unknown to us, however the appearance of a 
characteristic signal at 4.78-4.73 ppm in the 
1
H NMR spectrum and a new carbonyl signal 
at 207.8 ppm in the 
13
C NMR spectrum suggested the formation of a ketone at C(6). The 
ratio of intensity between the new multiplet and the C(6) proton of (-)-20 was 3:1, which 
would correspond to the ratio of 87 to (-)-1, if this multiplet was in fact the C(5) proton of 
the ketone 87. Conditions were screened, using racemic threo-hydroxylactone ()-20, in 
an attempt to increase conversion, while the reaction was repeated using vinyl acetate, 
which was known to favour the formation of oxidized by-product in an attempt to 
identify the unknown by-product from acetylation using PCPA (Table 10). 
Table 10. Screening Conditions for Dynamic Kinetic Transformation 
Entry 
Time 
(days) 
Atm. 
Temp. 
(C) 
Donor Lipase 
Conv.
(%)
(f)
 
Ratio 
  
 - - 
(g)
 
1 2 N2 70 PCPA
(a)
 CALB
(c)
 32 3 
2 2 N2 50 PCPA
(a)
 CALB
(c)
 31 3 
3 2 H2 70 PCPA
(a)
 CALB
(c)
 32 3 
4 5 N2 70 PCPA
(a)
 CALB
(d)
 32 3 
5 7 N2 70 PCPA
(b)
 CALA
(d)
 32 3 
6 17
(e)
 N2 70 PCPA
(b)
 CALB
(e)
 33 3 
7 24 N2 70 PCPA
(b)
 CALA
(d)
 33 3 
8 2 N2 70 VA
(a)
 CALB
(c)
 52 10 
All reactions were conducted as described in the general method outlined in the 
experimental section. The acyl donors used were p-chlorophenylacetate (PCPA, 100) and 
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vinyl acetate (VA). (a) Reaction was conducted using 10 equivalents of acyl donor. (b) 
Reaction was conducted using 15 equivalents of acyl donor. (c) Reaction was conducted 
using 85mg/mmol of immobilized lipase. (d) Reaction was conducted using 270 
mg/mmol of immobilized lipase. (e) Reaction was initially conducted using 270 
mg/mmol of immobilized lipase (86 mg), then 71 mg of lipase was added on days 9, 13, 
15, 16. (f) Conversion was determined from the percentage of recovered starting material. 
(g) Estimated from 
1
H NMR spectrum of the product co-eluting 87 and ()-1. 
It was initially thought that conversion was ceasing due to a thermal deactivation of the 
enzyme, however lower reaction temperature had no effect on the outcome of the reaction 
(Entry 2, Table 10). The reaction was repeated under a hydrogen atmosphere (1 atm) in 
an attempt to reduce the steady state concentration of the suspected oxidized product, 
with no success (Entry 3, Table 10). It was considered that the overall slowing of 
conversion was an effect of equilibrium control of the reaction and a series of conditions 
were screened to improve conversion with increased lipase loading, acyl donor 
equivalents and reaction time, none of which produced even a minimal effect on 
conversion or reduction of biproduct (Entries 4-6, Table 10). The CALB N435 
immobilized enzyme was replaced with CALA enzyme immobilized on immobead150 to 
probe the effect of enzyme and immobilization medium, yet no effect on reaction 
parameters was observed (Entry 5 and 7, Table 10). Interestingly, successive additions of 
fresh immobilized lipase after conversion had ceased did not result in additional 
conversion of starting material (Entry 6, Table 10). Equilibrium considerations and the 
thermal or otherwise slow decay of enzyme could be ruled out as sources for the 
conversion limit based on these results. Instead, it was concluded that a species formed 
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during the course of the reaction was responsible for the inactivation of lipase once a 
threshold concentration was reached. Attempted DKT using vinyl acetate as a donor 
resulted in increased consumption of starting material, however the isolated material 
consisted almost exclusively of by-product (Entry 8, Table 10). Comparison of 
1
H NMR, 
13
C NMR spectra of the product isolate showed a very strong correlation with that 
isolated from previous attempts using PCPA as a donor. The mechanism for the 
activation of the oxidation pathway by the hydrolytic products with a vinyl acetate donor 
is established (Scheme 30).
40
  
 
Scheme 30. The Oxidation of Starting Material Due to Acetaldehyde 
When the spectral correlation between the two by-products is considered together with 
the characteristic signals suggesting the formation of a ketone at C(6), a convincing 
argument can be made for the tentative structural assignment of the by-product as 87. 
Regardless of the structure of the by-product, it is clear from 
13
C NMR spectra that the 
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by-product contained a highly deshielded carbon (208 ppm) that could compete with 
electrophilic acyl donor (169 ppm) for the nucleophilic serine in the active site of the 
lipase. The competitive reversible inhibition of lipases by methyl-n-alkyl ketones and 
aldehydes has been known for some time.
51
 Although inhibition of the lipase under 
reaction conditions appeared to be irreversible due to the complete halt of conversion at 
~30 %, the suspected oxidized by-product 87 cannot be ruled out as the source of 
inhibition, as its lactone moiety provides a convenient hydrogen-bond acceptor handle 
that could lead to greater binding affinity for the active site and therefore lead to 
irreversible inhibition.  
3.0 Conclusions and Outlook 
 
3.1 Racemic Synthesis
17
 
The diastereoselective synthesis of the biologically active erythro-6-acetoxy-5-
hexadecanolide was achieved in 33 % overall yield using a benign chemoenzymatic 
domino epoxidation-lactonization procedure. The E-factor for this oxidation/cyclization 
process was ~0.4, while the E-factor for the overall synthesis starting from 5-
bromovaleric acid and undecanal was ~9, whereas E-factors in pharmaceutical production 
range between 25 and 100.
48a, b
 A technique used in industrial purification of plant oils 
was demonstrated as a practical means of purifying a fatty acid from Wittig reactions on a 
gram scale. The threo-diastereomer was synthesized in 44 % overall yield. 
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 At this stage the reliance on conventional means for the synthesis of fatty acid 72, 
and acetylation to afford (±)-1 has, as illustrated by E-factors provided in the 
experimental, introduced the largest volume of waste, and required the use of non-benign 
solvents. The benign oxidation procedure utilized in this work has nevertheless 
significantly improved upon the ‘greeness’ of the synthesis from previous attempts that 
also relied on such non-benign solvents as DCM and toluene.  
 Ongoing work is focused on reducing the environmental impact of the process by 
addressing the limitations associated with the Wittig olefination and 
epimerization/acetylation steps. In keeping within the tenets of green chemistry,
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catalytic approaches to acetylation and epimerization of C(6) are being considered. To 
obtain the desired relative geometry, aqueous hydrolysis of the mesylate followed by 
lipase catalyzed acetylation is being explored as an alternative to the conventional 
approach taken in this work. At the same time, methods for obtaining cis-5-hexadecenoic 
acid from plant or microbial sources are being explored. The overall long term aims of 
this research effort are to further improve the synthesis of MOP with reduced overall 
waste output to render its use in mosquito control applications more feasible. 
3.2 Asymmetric Synthesis 
It was demonstrated that an asymmetric epoxidation of the fatty acid 72 was an 
efficient means to synthesize enantioenriched MOP (-)-1 or the diastereomer (-)-2. High 
enantioselectivity (10:1 dr) for the (-)-20 was observed for the epoxidation with the chiral 
ketone 84d. Reactions using the shorter chain alkyl substituted ketones 84b, c produced 
less optically active material in order of decreasing chain length.  
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 The lengthy and technically challenging synthesis of the catalyst 84d detracts 
from the practicality of this synthesis. Nonetheless, it provides evidence that 
enantioenriched alkyl lactones of the form (-)-20 and (-)-10 can be synthesized from 
unsaturated fatty acids using epoxidation and the amphiphilic nature of the substrate can 
be exploited for stereoinduction. The correlation between the formation of mixed 
aggregates in the epoxidation system and enantioselectivity should be investigated. 
Catalysts based on this concept could prove to become a powerful tool in asymmetric 
catalysis in the future. 
 The attempted DKT by lipase mediated acetylation of lactone 20 was 
unsuccessful. Reaction conversion would halt at ~7.5 %, with most of the isolated 
product material consisting of what is thought to be the ketone derivative 87. This by-
product was almost the exclusive product isolated from DKT using vinyl acetate as an 
acyl donor. The unusually downfield carbonyl carbon signal of the ketone suggested that 
the C(6) carbon was the more electrophilic carbonyl center among those reagents present 
in the reaction. It was suspected that this ketone was responsible for the inhibition of 
lipase.  
  
66 
 
4.0 Experimental 
 
4.1 General Procedures 
Reagents and solvents were purchased at the highest available purity from Sigma-Aldrich 
and subsequently used from the shelf without further purification, unless otherwise stated. 
For use in PCPA synthesis p-chlorophenol was purified by vacuum distillation. Dry 
solvents were obtained by distillation under N2 from CaH (DCM) or Na (toluene and 
THF). Procedure for the preparation of sodium tert-amyl oxide solution can be found in 
Appendix A1.2. Reactions were monitored by thin layer chromatography (TLC) using 
TLC silica gel plates 60 F254, EMD Merck. Flash column chromatography was 
performed over Silicycle ultrapure silica gel (230-400 mesh). NMR spectra were obtained 
with a Bruker DPX-300 (
1
H 300 MHz or 
1
H 600 MHz, 
13
C 75.5 MHz, 
15
N 60.8 MHz, 
19
F 
292 MHz) in CDCl3. The chemical shifts are reported as δ values (ppm) relative to 
tetramethylsilane for 
1
H NMR, 
13
C NMR. Enantiomeric excess was measured on an 
Agilent 1100 series high pressure liquid chromatography (HPLC) with equipped with an 
OD-H column. Mass spectra were obtained on an MSI/Kratos concept IS Mass 
spectrometer. Optical rotations were recorded on a Perkin Elmer 341 with sodium lamp 
polarimeter. FT-IR spectra were obtained on an ATI Mattson Research Series 
spectrometer. Melting points were uncorrected. Elemental analysis was performed by 
combustion and gravimetric determination at Atlantic Microlab. 
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4.2 Detailed Experimental Procedures 
The procedures outlined in this section were previously published in reference 17. 
 
(4-Carboxybutyl)triphenylphosphonium bromide (89): 
A solution of triphenylphosphine (16.3 g, 62.3 mmol), and 5-bromovaleric acid (10.2 g, 
56.1 mmol) in dry toluene (85 ml) was heated under reflux for 24 h. Toluene was 
removed in vacuo at 70 C. Ether (20 ml) was added to the resulting amorphous solid and 
shaken vigorously. The white precipitate was filtered, washed with ether (3 x 15 ml) and 
dried in vacuo for 4 h at 35 C to yield the title compound as a white solid that was used 
in subsequent reactions without further purification (21.6 g, 86 %, E = 0.2). m.p.: 191-
193 C (toluene-ether); 1H NMR (300 MHz, DMSO-d6):  12.5 (s, 1H), 7.82 (m, 15H), 
3.64 (m, 2H), 2.30 (t, J = 7.2 Hz, 2H), 1.68 (m, 4H); 
13
C NMR (300 MHz, DMSO-d6):  
174.5, 135.38, 135.35, 134.1, 134.0, 130.8, 130.6, 118.6, 118.4, 33.06, 25.8, 25.6, 21.7, 
20.8, 20.14. 
 
 (Z)-5-Hexadecenoic acid (72): 
To a flame-dried flask containing 4-(carboxybutyl)triphenylphosphonium bromide (6.01 
g, 13.6 mmol), was added an 0.8 M solution of sodium t-amylate in t-amyl alcohol and 
1:1 toluene:THF (38 ml), at 0 C, under a nitrogen atmosphere and with moderate to fast 
68 
 
stirring with a magnetic stir bar. To the resulting viscous orange suspension was added 
undecanal (2.54 g, 14.9 mmol) over 10 minutes with vigorous stirring under the 
conditions described above. The reaction was allowed to warm to room temperature 
overnight. The cream coloured mixture was extracted with H2O (4 x 10 ml). The 
combined aqueous phase was cooled in an ice bath and slowly brought to pH ~2 by 
dropwise addition of aqueous 2% H2SO4 solution, extracted with ether (3 x 10 ml), 
combined organic layers were dried (MgSO4) and concentrated to a clear yellow oil (3.62 
g). The crude oil was dissolved in methanol (6.6 ml) and transferred hot to a boiling 
solution of urea in methanol (16.5 g in 26 ml). The solution was allowed to crystallize 
overnight then filtered. The collected urea crystals were dissolved in 2% H2SO4, 
extracted with ether (3 x 10 ml), dried (MgSO4), and ether was removed in vacuo to yield 
7 as clear, nearly colourless oil containing about 10 % aromatic impurities by 
1
H NMR 
(2.78 g). The analytically pure fatty acid was obtained by repeating the above process to 
yield 7 as a clear, colourless oil (2.56 g, 74 %, Z:E = 8:2, E = 3.6). 
1
H NMR (600 MHz, 
CDCl3):  11.5 (s, 1H), 5.46-5.32 (m, 2H), 2.36 (t, J = 6.7 Hz, 2H), 2.14-2.01 (m, 4H), 
1.74-1.70 (m, 2H), 1.35-1.10 (m, 18 H), 0.92-0.87 (t, J = 6.7 Hz, 3H) ; 
13
C NMR (600 
MHz, CDCl3):  180.5, 131.3, 128.1, 33.4, 31.9, 29.8-29.2, 27.3, 26.5, 24.5, 22.6, 14.1; 
IR (KBr pellet): ν 3500-2500, 2920, 2856, 1710, 1460, 1410, 935 cm-1; HRMS (FAB): 
m/z calcd for C16H30O2 [M + H]
+
, 255.2324;found, 255.2304. Characterization data were 
in good agreement with literature.
12c
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threo-6-Hydroxy-5-hexadecanolide (()-20): 
A solution of fatty acid 72 (376 mg, 1.48 mmol) in cyclohexane (7 ml) was added in 
aliquots (2 ml) to a vial containing CALB on Immobead 150
TM
 (126 mg) with gentle 
stirring over 24 h. At the same time, to the above mixture was added 15 M aqueous H2O2 
at a rate of 0.04 ml/h via syringe pump and PTFE tubing (0.8 ml). Reaction mixture was 
stirred for an additional 24 h upon addition of all reagents, then filtered; phases were 
separated, the combined organic layer was dried (MgSO4), adjusted to 27 ml with 
cyclohexane with 0.04 % (v/v) Et3N then heated under reflux for 12 h. The resulting 
solution was concentrated and ()-20 was crystallized from hot hexane as a white solid 
containing only the threo-diastereomer ()-20 (196 mg, 48 %). The mother liquor was 
concentrated and purified by flash chromatography (1:1 hexane/EtOAc 0.02 % Et3N) to 
yield ()-20 as a white solid (79 mg, 21 %). The two were combined to yield ()-20 as a 
white powder (275 mg, 69 %, E = 0.4) mp: 65-67 
o
C (hexanes), lit.
8g
 68-70 
o
C (hexanes-
EtOAc); 
1
H NMR (300 MHz, CDCl3):  4.2 (m, 1H), 3.6 (m, 1 H), 2.6-2.5 (m, 2H), 2.0-
1.2 (m, 22H), 0.9 (t, J = 6.7 Hz, 3H); 
13
C NMR (300 MHz, CDCl3):  171.6, 83.2, 73.3, 
32.6, 31.9, 29.5, 25.4, 24.2, 22.7, 18.4, 14.1; IR (KBr pellet): ν 3554(br), 2955, 1706 
cm
-1
; HRMS (FAB): m/z calcd for C16H30O3 [M + H]
+
 271.2273, found 271.2258; Anal. 
Calcd for C16H30O3: C, 71.07; H, 11.18. Found: C, 70.77; H, 11.15. Characterization data 
were in good agreement with literature.
8g
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threo-6-Acetoxy-5-hexadecanolide ((±)-2): 
To a solution of lactone (±)-20 (342 mg, 1.27 mmol) in CH2Cl2 (7.6 ml) was added Ac2O 
(0.72 ml, 7.56 mmol) and pyridine (0.61 ml, 7.56 mmol) at 0 
o
C under nitrogen. The 
reaction was allowed to slowly warm to room temperature. Upon stirring for 40 h the 
reaction was quenched by addition of brine (18 ml) and stirred vigorously for an 
additional 30 minutes. The mixture was extracted with CH2Cl2 (3 x 10 ml), the combined 
organic layers were dried (MgSO4), concentrated and purified by flash chromatography 
(1:1 hexane-EtOAc 0.01 % Et3N) to yield (±)-2 as a clear colourless oil (392 mg, 98 %, E 
= 0.3). 
1
H NMR (300 MHz, CDCl3):  5.00 (m, 1H), 4.37 (dt, J = 4.5, 3.6, 1 H), 2.60-
2.47 (m, 2H), 2.11 (s, 3H), 2.01-1.50 (m, 6H), 1.27 (s, 16H) 0.9 (t, J = 6.7 Hz, 3H); 
13
C 
NMR (300 MHz, CDCl3):  170.9, 170.7, 79.8, 73.9, 31.9, 29.9-29.3, 25.3, 24.1, 22.7, 
21.0, 18.4, 14.1; HRMS (EI): m/z calcd for C18H32O4 [M ]
+
 312.2301, found 312.2313. 
Characterization data were in good agreement with literature.
8g
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erythro-6-Acetoxy-5-hexadecanolide ((±)-1): 
A flame-dried two neck flask equipped with a magnetic stir bar, rubber septum and a 
vacuum adapter connected to a two-line Schlenk manifold was charged with a solution of 
threo-hydroxylactone (±)-20 (164.7 mg, 0.609 mmol) in CH2Cl2 (15 ml) under N2. The 
above solution was cooled in an ice bath then MsCl (0.05 ml, 0.646 mmol) and Et3N 
(0.05 ml, 0.358 mmol) were added dropwise at 0 
o
C under N2. The reaction flask was 
allowed to warm to room temperature over 0.5 h, then the reaction mixture was washed 
with water (10 ml), sat. NaHCO3 (10 ml) and brine (10 ml), then dried (MgSO4) and 
concentrated. The crude mesylate was further dried under vacuum (0.1 mmHg, 40 
o
C, 2 
h), then dissolved in dry toluene (15 ml) under N2. To a flame-dried two neck flask 
equipped with a magnetic stir bar, septum and condenser attached to a two-line Schlenk 
manifold was added CsOAc (311.8 mg, 1.628 mmol) and 18-crown-6 (180.3 mg, 0.682 
mmol) under a rapid flow of nitrogen. The contents of the reaction flask were further 
dried by vacuum purging and backfilling with N2 three times at 100 
o
C. The mesylate 
solution was transferred to the reaction flask via cannula with rapid stirring under N2. The 
reaction mixture was heated under reflux for 16 h. The mixture was then cooled to room 
temperature, poured into Et2O (30 ml) and washed with water (10 ml), sat. NaHCO3 (10 
ml) and brine (10 ml), then dried (MgSO4), concentrated and purified by flash 
chromatography (2:1 hexane-EtOAc 0.02 % Et3N) to afford (±)-1 as a clear colourless oil 
(139.8 mg, 73 %, E = 4.5). 
1
H NMR (300 MHz, CDCl3):  4.95 (m, 1H), 4.32 (m, 1 H), 
2.56-2.39 (m, 2H), 2.04 (s, 3H), 2.01-1.70 (m, 3H), 1.62 (m, 3H) 1.22 (s, 16H) 0.84 (t, J 
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= 6.7 Hz, 3H); 
13
C NMR (300 MHz, CDCl3):  170.8, 170.4, 80.5, 74.2, 31.8, 29.6-29.3, 
25.2, 23.4, 22.6, 21.0, 18.3, 14.1; HRMS (EI): m/z calcd for C18H32O4 [M ]
+
 312.2301, 
found 312.2303. Characterization data were in good agreement with literature.
8g
 
 
Catalysts 84b-d were synthesized according to previously outlined representative 
synthetic procedures.
37a, b 
Shi epoxidation conditions were based on published 
representative epoxidation procedures.
37c 
Characterization data for catalysts were in good 
agreement with literature.
37a
 
  
Catalyst (84b): 
White granular crystals; m.p. 162-163 C (hexanes-EtOAc), lit.37a 162.0-163.5 C 
(hexanes-EtOAc); 
1
H NMR (300 MHz, CDCl3):  7.42 (d, J = 8.4 Hz, 2H), 7.21 (d, J = 
8.4 Hz, 2H), 4.89 (d, J = 5.4 Hz, 1H), 4.78-4.75 (d, J = 10.5 Hz, 1H), 4.67-4.64 (m, 2H), 
4.31-4.26 (d, J = 14.1 Hz, 1H), 3.78-3.75 (d, J = 10.2 Hz, 2H), 2.36 (s, 3H), 1.50 (s, 3H), 
1.45 (s, 3H); 
13
C NMR (300 MHz, CDCl3):  195.1, 151.2, 134.8, 134.5, 129.8, 118.8, 
111.1, 99.1, 77.5, 75.5, 60.9, 49.8, 27.1, 26.0, 20.8. 
Catalyst (84c): 
Clear plate-like crystals; m.p. 135-136 C (hexanes-EtOAc), lit.37a 135-136 C (hexanes-
EtOAc); 
1
H NMR (300 MHz, CDCl3):  7.44 (d, J = 9.3 Hz, 2H), 7.23 (d, J = 9.3 Hz, 
2H), 4.89 (d, J = 5.4 Hz, 1H), 4.78-4.74 (d, J = 10.5 Hz, 1H), 4.67-4.64 (m, 2H), 4.31-
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4.26 (d, J = 13.8 Hz, 1H), 3.78-3.75 (d, J = 10.5 Hz, 2H), 2.65 (m, 2H), 1.50 (s, 3H), 1.45 
(s, 3H), 1.23 (t, 3H); 
13
C NMR (300 MHz, CDCl3):  195.1, 151.2, 141.2, 134.6, 128.6, 
118.9, 111.1, 99.1, 75.5, 60.9, 49.8, 28.2, 27.1, 26.0, 15.6. 
Catalyst (84d): 
Clear plate-like crystals. m.p. 165-166 C (hexanes-EtOAc), lit.37a 164-166 C (hexanes-
EtOAc); 
1
H NMR (300 MHz, CDCl3):  7.45 (d, J = 8.7 Hz, 2H), 7.21 (d, J = 8.7 Hz, 
2H), 4.89 (d, J = 5.4 Hz, 1H), 4.78-4.74 (d, J = 10.5 Hz, 1H), 4.67-4.62 (m, 2H), 4.30-
4.26 (d, J = 13.2 Hz, 1H), 3.78-3.75 (d, J = 10.5 Hz, 2H), 2.61 (m, 2H), 1.59 (m, 2H), 
1.50 (s, 3H), 1.45 (s, 3H), 1.33 (m, 2H), 0.93 (t, 3H); 
13
C NMR (300 MHz, CDCl3):  
195.1, 151.2, 139.9, 134.6, 129.2, 118.8, 111.1, 99.1, 75.5, 60.9, 49.8, 34.9, 33.6, 27.1, 
26.0, 22.24, 13.9.  
 
  
(5R, 6R)-6-hydroxy-5-hexadecanolide ((-)-20) by Representative Shi Epoxidation: 
To a solution of fatty acid 72 (200 mg, 0.786 mmol) and catalyst 84d (76 mg, 0.196 
mmol) in DME-DMM 3:1 (12 ml) was added an aqueous buffer (7.9 ml, 0.1 M AcOH-
K2CO3 pH 9.3 in 0.4 mM aqueous EDTA) and Bu4NHSO4 (10 mg, 0.031 mmol) with 
vigorous stirring. The solution was cooled in a -11 
o
C ice-salt bath for 15 minutes then 
solutions of Oxone (6.3 ml, 0.20 M in 0.4 mM aqueous EDTA) and K2CO3 (6.3 ml, 0.84 
M in 0.4 mM aqueous EDTA) were delivered simultaneously over 6 hours. The solution 
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was adjusted to pH ~2 by slow addition of 10% HCl (3.5 ml), extracted with EtOAc (3 x 
10ml), dried (MgSO4), filtered and concentrated. The crude oil was dissolved in 
cyclohexane (14 ml) and heated under reflux for 24 hours. The resulting yellow solution 
was concentrated and purified by flash chromatography (Et2O) then recrystallized from 
hexanes to afford the target compound (-)-20 as a white solid (149 mg, 70 %). m.p. 65-
66 
o
C (hexanes), lit.
8g
 68-70 
o
C (hexanes-EtOAc); []D -9.3
o
 (c = 0.95, CHCl3); lit.
8g
 -
10.2
 o
 (c = 0.87); 
1
H NMR (300 MHz, CDCl3):  4.2 (m, 1H), 3.6 (m, 1 H), 2.6-2.5 (m, 
2H), 2.0-1.2 (m, 22H), 0.9 (t, J = 6.7 Hz, 3H); 
13
C NMR (300 MHz, CDCl3):  171.6, 
83.2, 73.3, 32.6, 31.9, 29.5, 25.4, 24.2, 22.7, 18.4, 14.1; IR (KBr): ν 3554(br), 2955, 1706 
cm
-1
;HRMS (FAB): m/z calcd for C16H30O3 [M + H]
+
 271.2273, found 271.2262.  
 
Hydroxylactone ((-)-20) using catalyst (84b): 
Starting with fatty acid 72 (254 mg, 1.00 mmol) the representative epoxidation procedure 
using catalyst 84b was followed to synthesise (-)-20 as a white solid (175 mg, 65 %). m.p 
65-67 
o
C (hexanes), lit.
8g
 68-70 
o
C (hexanes-EtOAc); []D -6.5
o 
(c = 1.04, CHCl3); 
lit.8g  -10.2 o (c = 0.87, CHCl3); 
1
H NMR (300 MHz, CDCl3):  4.2 (m, 1H), 3.6 (m, 1 H), 
2.6-2.5 (m, 2H), 2.0-1.2 (m, 22H), 0.9 (t, J = 6.7 Hz, 3H); 
13
C NMR (300 MHz, CDCl3): 
 171.6, 83.2, 73.3, 32.6, 31.9, 29.5, 25.4, 24.2, 22.7, 18.4, 14.1. 
Hydroxylactone ((-)-20) using catalyst (84c): 
Starting with fatty acid 72 (255 mg, 1.00 mmol) the representative epoxidation procedure 
using catalyst 84c was followed to synthesis (-)-20 as a white solid (183 mg, 68 %). m.p. 
65-67 
o
C (hexanes), lit.
8g
 68-70 
o
C (hexanes-EtOAc); []D -8.6
o
(c = 1.01, CHCl3), 
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lit.
8g
 -10.2
 o
 (c = 0.87, CHCl3); 
1
H NMR (300 MHz, CDCl3):  4.2 (m, 1H), 3.6 (m, 1 H), 
2.6-2.5 (m, 2H), 2.0-1.2 (m, 22H), 0.9 (t, J = 6.7 Hz, 3H); 
13
C NMR (300 MHz, CDCl3): 
 171.6, 83.2, 73.3, 32.6, 31.9, 29.5, 25.4, 24.2, 22.7, 18.4, 14.1. 
Characterization data were in good agreement with literature for all asymmetric 
epoxidation products.
8g 
  
(5R, 6R)-6-(OBz)-5-Hexadecanolide (95) with chirality from catalyst (84d): 
To a solution of lactone (-)-20 (43 mg, 0.16 mmol) in CH2Cl2 (1.0 ml) was added BzCl 
(0.11 ml, 0.95 mmol), pyridine (0.08 ml, 0.95 mmol) and DMAP (1.4 mg, 0.012 mmol) 
at 0 
o
C under nitrogen. The reaction was allowed to slowly warm to room temperature. 
Upon stirring for 2.5 h the reaction was quenched by addition of brine (3 ml) and stirred 
vigorously for an additional 30 minutes. The mixture was extracted with CH2Cl2 (3 x 10 
ml), the combined organic layers were dried (MgSO4) and concentrated. Hexane-EtOAc 
(3:1, 1 ml) was added to the residue, the resulting white precipitate was removed by 
filtration and the filtrate was concentrated and purified by flash chromatography (3:1 
hexane-EtOAc 0.01 % Et3N) to yield 95 as a clear colourless oil (51 mg, 85 %).; []D: -
10.1 (c = 1.05, CHCl3); 
1
H NMR (300 MHz, CDCl3):  8.08 (m, 2H), 7.59 (m, 1H), 7.47 
(m, 2H), 5.27 (m, 1H), 4.52 (m, 1H), 2.62-2.46 (m, 2H), 2.01-1.59 (m, 6H), 1.48-1.25 (m, 
16H), 0.88 (t J = 6.7 Hz, 3H); 
13
C NMR (300 MHz, CDCl3):  171.0, 166.1, 133.3, 129.8, 
128.5, 79.9, 74.4, 31.9, 30.1, 29.7, 29.5, 29.4, 29.3, 25.5, 24.3, 22.7, 18.4, 14.1; er: 10:1 
76 
 
[HPLC, ChiralcelOD, hexane-isopropanol 95:5, 1.5 ml/minute, rt (area) = 11.65(584.4) 
and 13.90(57.2)]. Characterization data were in good agreement with literature.
53 
  
(5R, 6R)-6-Acetoxy-5-hexadecanolide ((-)-2) with chirality from catalyst (84d): 
To a solution of lactone (-)-20 (50 mg, 0.18 mmol) in CH2Cl2 (1.2 ml) was added Ac2O 
(0.11 ml, 1.2 mmol), pyridine (0.10 ml, 1.2 mmol) and DMAP (1.4 mg, 0.012 mmol) at 0 
o
C under nitrogen. The reaction was allowed to slowly warm to room temperature. Upon 
stirring for 0.5 h the reaction was quenched by addition of brine (3 ml) and stirred 
vigorously for an additional 30 minutes. The mixture was extracted with CH2Cl2 (3 x 10 
ml), the combined organic layers were dried (MgSO4), concentrated and purified by flash 
chromatography (1:1 hexane-EtOAc 0.01 % Et3N) to yield (-)-2 as a clear colourless oil 
(54 mg, 97 %).; []D -13.0 (c = 2.0, CHCl3), lit.
8n
 -14.4 (c = 2.2, CHCl3); 
1
H NMR (300 
MHz, CDCl3):  5.00 (m, 1H), 4.37 (dt, J = 4.5, 3.6, 1 H), 2.60-2.47 (m, 2H), 2.11 (s, 
3H), 2.01-1.50 (m, 6H), 1.27 (s, 16H) 0.9 (t, J = 6.7 Hz, 3H); 
13
C NMR (300 MHz, 
CDCl3):  170.9, 170.7, 79.8, 73.9, 31.9, 29.9-29.3, 25.3, 24.1, 22.7, 21.0, 18.4, 14.1. 
  
(5R, 6S)-6-acetoxy-5-hexadecanolide ((-)-1) with chirality from catalyst (84d): 
A flame-dried two neck flask equipped with a magnetic stir bar, rubber septum and a 
vacuum adapter connected to a two-line Schlenk manifold was charged with a solution of 
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(5R, 6R)-hydroxylactone (-)-20 (52 mg, 0.19 mmol) in CH2Cl2 (5 ml), under N2. The 
above solution was cooled in an ice bath then MsCl (0.02 ml, 0.2 mmol) and Et3N (0.02 
ml, 0.1 mmol) were added dropwise at 0 
o
C under N2. The reaction flask was allowed to 
warm to room temperature over 0.5 h, then the reaction mixture was washed with water 
(3 ml), sat. NaHCO3 (3 ml) and brine (3 ml), then dried (MgSO4) and concentrated. The 
crude mesylate was dried under vacuum (0.1 mmHg, 40 
o
C, 2 h), then dissolved in dry 
toluene (5 ml) under N2. To a flame-dried two neck flask equipped with a magnetic stir 
bar, septum and condenser attached to a two-line Schlenk manifold was added CsOAc 
(92 mg, 0.48 mmol) and 18-crown-6 (56 mg, 0.21mmol) under a rapid flow of nitrogen. 
The contents of the reaction flask were further dried by vacuum purging and backfilling 
with N2 three times at 100 
o
C. The mesylate solution was transferred to the reaction flask 
via cannula with rapid stirring under N2. The reaction mixture was heated under reflux for 
16 h. The mixture was then cooled to room temperature, poured into Et2O (10 ml) and 
washed with water (3 ml), sat. NaHCO3 (3 ml) and brine (3 ml), then dried (MgSO4), 
concentrated and purified by flash chromatography (2:1 hexane-EtOAc 0.02 % Et3N) to 
afford (-)-1 as a clear colourless oil (46 mg, 77 %). []D: -34.1 (c = 2.0, CHCl3), 
lit.
8g
 -38.1 (c = 1.02 CHCl3);  
1
H NMR (300 MHz, CDCl3):  4.95 (m, 1H), 4.32 (m, 
1H), 2.56-2.39 (m, 2H), 2.04 (s, 3H), 2.01-1.70 (m, 3H), 1.62 (m, 3H) 1.22 (s, 16H) 0.84 
(t, J = 6.7 Hz, 3H); 
13
C NMR (300 MHz, CDCl3):  170.8, 170.4, 80.5, 74.2, 31.8, 29.6-
29.3, 25.2, 23.4, 22.6, 21.0, 18.3, 14.1. Characterization data were in good agreement 
with literature.
8g 
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4-Chlorophenyl acetate (100): 
In a 10 ml microwave vial, was added Ac2O (1.0 ml) and silica gel (1.0 g) and stirred 
until a uniform silica paste was formed. To the above mixture was added 4-chlorophenol 
(521 mg, 4.06 mmol) and heated at 135 
o
C for 2.5 min using microwave radiation. The 
mixture was extracted with hexane (3 x 4 ml), dried (MgSO4), filtered and residual 
solvent and acetic acid was removed under reduced pressure (0.1 mmHg, 30 
o
C, 3 h) to 
yield the title compound as a brown liquid (548 mg, 79 %). 
1
H NMR (300 MHz, CDCl3): 
 7.35 (d, 2H), 7.05 (d, 2H), 2.30 (s, 3H); 13C NMR (300 MHz, CDCl3):  169.1, 149.2, 
131.1, 129.5, 123.0, 21.0. Characterization data were in good agreement with literature.
50
 
 
Synthesis of Shvo’s Catalyst (85): 
To a flame dried two neck flask equipped with an oval magnetic stir bar, septum, and 
flame dried condenser connected to a two line Schlenk manifold was added triruthenium 
dodecacarbonyl (100 mg, 0.157 mmol) and tetraphenylcyclopentadienone (181 mg, 0.470 
mmol) under a rapid flow of N2. The flask was charged with anhydrous methanol (17 ml) 
and heated under reflux for 24 h. The reaction was cooled to room temperature and the 
yellow precipitate was collected by vacuum filtration and washing with hexanes (3 x 1 
ml). Drying under reduced pressure afforded catalyst 85 as a bright yellow powder (174 
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mg, 39 %). 
1
H NMR (300 MHz, benzene-d6):  13.8 (s, 1H), 7.46 (m, 8H), 7.09 (m, 8H), 
6.91 (m, 12 H), 6.72 (m, 12H), -17.75 (s, 1H); 
13
C NMR (300 MHz, CDCl3). 
Characterization data were in good agreement with literature.
41
 
Epimerization of (()-20) to (()-10) using Shvo`s Catalyst (85): 
A flame-dried flask was charged with ()-20 (48 mg, 0.179 mmol), Shvo`s catalyst 85 (2 
mg, 0.002 mmol) and toluene (0.85 ml) under H2 (1 atm) and heated at 70 C for 24 h. 
The solution was isolated by filtration, concentrated and purified by flash 
chromatography (1:1 hexanes:EtOAc) and subsequently prepared for analysis by NMR in 
CDCl3. See Appendix A3.18for NMR spectra. 
Attempted dynamic kinetic transformation of (()-20) using vinyl acetate donor: 
A flame dried two-neck flask, equipped with stir-bar was charged with ()-20 (45 mg, 
0.166 mmol), 85 (2 mg, 0.002 mmol) and CALB (N435, 18 mg) and dried by evacuating 
and flushing with N2 three times. A second flame dried flask was charged with vinyl 
acetate (0.16 ml, 1.73 mmol) and dry toluene (0.83 ml) under N2. The solution of vinyl 
acetate was dried by passing dry N2 through the solution via syringe needle for 1 h and 
then transferred via cannula to the two neck flask using a positive pressure of N2. The 
reaction mixture was heated under N2 for 48 h, the solution was isolated by filtration, 
concentrated under reduced pressure and purified by flash chromatography (2:1 then 1:1 
hexane-EtOAc 0.02 % Et3N). Starting material was recovered as a mixture of 
diastereomers (21.6 mg, 48 %). The product suspected to be 87 was isolated with trace 
(~10 %) acetylated starting materials as clear oil. (28.0 mg) 
1
H NMR (300 MHz, CDCl3): 
 4.75 (m, 1H), 2.67-2.57 (m, 3H), 2.18-2.10 (m, 4H), 1.59 (m, 2H), 1.25 (s, 14H), 0.88 
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(t, 3H); 
13
C NMR (300 MHz, CDCl3):  207.8, 169.7, 83.3, 38.4, 31.9, 29.6, 29.5, 29.4, 
29.3, 29.1, 24.3, 22.9, 22.7, 19.9, 14.1. 
Representative Dynamic kinetic transformation of chiral hydroxylactone ((+)-20) 
using PCPA (100): 
A flame dried two-neck flask, equipped with stir-bar was charged with ()-20 (86 mg, 
0.325 mmol), 85 (7 mg, 0.006 mmol) and CALB (N435, 94 mg) and dried by evacuating 
and flushing with N2 three times. A second flame dried flask was charged with 100 (547 
mg, 3.21 mmol) and dry toluene (2.0 ml) under N2. The solution of vinyl acetate was 
dried by passing dry N2 through the solution via syringe needle for 1 h and then 
transferred via cannula to the two neck flask using a positive pressure of N2. The reaction 
mixture was heated under N2 for 48 h, the solution was isolated by filtration, concentrated 
under reduced pressure and purified by flash chromatography (2:1 then 1:1 hexane-
EtOAc 0.02 % Et3N). Starting material was recovered as a mixture of diastereomers (59, 
69 %). The product suspected to be 87 was isolated with trace (~25 %) acetylated starting 
materials as clear oil. (28.0 mg, see Appendix A3.20 and A3.21 for NMR spectra)  
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Appendix: 
 
A1 Supporting Experimental Procedures 
A1.1 Synthesis of (Z)-5-hexadecenoic acid (7) using t-BuOK base (Table 3, entry 1 in 
text): 
Phosphonium bromide (1.12 g, 2.53 mmol) and t-BuOK (750 mg, 6.33 mmol) were 
combined in a flame dried two neck flask equipped with an oval stir bar, a rubber septum 
on one neck and a vacuum adaptor connected to a two-line Schlenk tube on the side arm. 
The flask was evacuated then filled with N2 three times then cooled to 0 
o
C in an ice bath, 
and charged with freshly distilled THF (4 ml), under N2 and with stirring. The resulting 
deep orange slurry was stirred for 30 minutes then freshly distilled undecanal (464 mg, 
2.72 mmol) was added dropwise over 30 minutes with vigorous stirring. The resulting 
pale yellow suspension was slowly allowed to warm to room temperature overnight. The 
cream coloured suspension was then concentrated and placed under 0.1 mmHg at 40 
o
C 
for 3 h. To the amorphous residue was added water (10 ml) and the flask was left 
overnight allowing triphenylphosphine oxide to precipitate. The resulting solution was 
filtered and brought to pH ~2 by slow addition of 2 % H2SO4 then extracted with Et2O (4 
x 4 ml), dried (MgSO4), filtered and concentrated to afford a yellow oil (648 mg). The 
crude fatty acid residue (106 mg) was purified by flash chromatography (hexane then 
hexane/EtOAc 1:1) to afford the title compound as a clear colourless oil (47 mg, yield = 
45 %, Z:E = 9:1). 
1
H NMR (600 MHz, CDCl3):  11.5 (s, 1H) 5.46-5.32 (m, 2H), 2.36 (t, 
J = 6.7 Hz, 2H), 2.14-2.01 (m, 4H), 1.74-1.70 (m, 2H), 1.35-1.10 (m, 18 H) 0.92-0.87 (t, 
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J = 6.7 Hz, 3H) ; 
13
C NMR (600 MHz, CDCl3):  180.5, 131.3, 128.1, 33.4, 31.9, 29.8-
29.2, 27.3, 26.5, 24.5, 22.6, 14.1; IR (KBr pellet): ν 3500-2500, 2920, 2856, 1710, 1460, 
1410, 935 cm
-1
. 
The remaining crude extract (542 mg) was purified using the urea inclusion method as 
described in the main text to afford the title compound as a clear colourless oil (172  mg, 
yield = 32 %, Z:E = 9:1). 
1
H NMR (600 MHz, CDCl3):  11.5 (s, 1H) 5.46-5.32 (m, 2H), 
2.36 (t, J = 6.7 Hz, 2H), 2.14-2.01 (m, 4H), 1.74-1.70 (m, 2H), 1.35-1.10 (m, 18 H) 0.92-
0.87 (t, J = 6.7 Hz, 3H) ; 
13
C NMR (600 MHz, CDCl3):  180.5, 131.3, 128.1, 33.4, 31.9, 
29.8-29.2, 27.3, 26.5, 24.5, 22.6, 14.1; IR (KBr pellet): ν 3500-2500, 2920, 2856, 1710, 
1460, 1410, 935 cm
-1
. 
A1.2 Preparation of sodium t-amylate solution and determination of base: 
Generation of amylate solution in toluene-THF 
t-AmOH (100 ml) was heated under reflux with sodium (2.01 g) until sodium was 
dissolved. The resulting solution was distilled into dry toluene (100 ml) and sodium. The 
distillate was heated under reflux for 8 h then transferred hot via cannula into an oven 
dried glass bottle, fitted with a septum and containing dry THF (100 ml). The solution 
was stored under nitrogen and at -7 
o
C. 
Determination of Base concentration 
The above solution was warmed to room temperature then transferred (1.0 ml) to distilled 
water (10 ml) with phenolphthalein indicator. The mixture was titrated with HCl (1.0 M, 
0.82 ml) until a colour change was observed. 
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A2.0 Determination of Z:E Ratios 
Z:E ratio was calculated as the ratio of E- and Z- olefinic proton multiplets by 
1
H NMR. 
The corresponding spectra are provided below: 
A2.1 
1
H NMR Multiplet analyses: 
Fatty acid 72 synthesized using t-BuOK and isolated from column (Table 3, Entry 1 
in text) 
 
J = 10.2 Hz Major, Z:E = 8:2 
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Fatty acid 72 synthesized using t-BuOK and isolated from urea (Table 3, Entry 1 in 
text) 
 
J = 9.9  Hz Major, Z:E = 8:2 
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Fatty acid 72 synthesized using t-AmONa and isolated from urea (Table 3, Entry 2 
in text) 
 
J = 10.2  Hz Major, Z:E = 8:2 
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A3.0 NMR Spectra of Isolated Products and Synthetic Intermediates 
A3.1 (4-carboxybutyl)triphenylphosphonium bromide (89): 
1
H NMR, 300 MHz, DMSO-d6 
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13
C NMR, 300 MHz, DMSO-d6 
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A3.2 (Z)-5-hexadecenoic acid (72): 
1
H NMR, 600 MHz, CDCl3 
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13
C NMR, 600 MHz, CDCl3
 
 
  
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
1
4
.
1
0
2
2
.
7
1
2
4
.
4
3
2
4
.
6
0
2
6
.
4
3
2
7
.
2
5
2
9
.
2
1
2
9
.
3
3
2
9
.
3
8
2
9
.
5
4
2
9
.
5
7
2
9
.
6
6
2
9
.
7
0
3
1
.
8
1
3
1
.
9
4
3
2
.
5
8
3
3
.
3
8
3
3
.
4
8
1
2
8
.
1
0
1
2
8
.
6
1
1
3
1
.
3
7
1
3
1
.
9
2
1
8
0
.
4
9
1
8
0
.
5
7
96 
 
A3.3 threo-6-hydroxy-5-hexadecanolide (()-20): 
1
H NMR, 300 MHz, CDCl3 
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13
C NMR, 300 MHz, CDCl3 
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A3.4 threo-6-acetoxy-5-hexadecanolide ((±)-2): 
1
H NMR, 300 MHz, CDCl3 
 
  
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
0
.8
7
1
0
.8
9
4
0
.9
1
5
1
.2
6
8
1
.6
9
9
1
.8
4
7
1
.8
8
3
2
.1
1
4
2
.4
6
8
2
.4
9
2
2
.4
9
8
2
.5
9
4
2
.5
9
9
4
.3
4
3
4
.3
5
5
4
.3
6
6
4
.3
8
1
4
.3
9
2
4
.4
0
4
4
.9
7
0
4
.9
8
2
4
.9
9
5
5
.0
0
7
5
.0
1
6
5
.0
2
8
7
.2
8
1
2
.9
8
1
6
.0
0
6
.8
4
2
.8
5
2
.0
1
0
.9
6
0
.9
5
1D proton
1D proton
1D proton
1D proton
99 
 
13
C NMR, 300 MHz, CDCl3 
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A3.5 erythro-6-acetoxy-5-hexadecanolide ((±)-1): 
1
H NMR, 300 MHz, CDCl3 
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13
C NMR, 300 MHz, CDCl3 
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A3.6 Catalyst (84b): 
1
H NMR, 300 MHz, CDCl3 
 
13
C NMR, 300 MHz, CDCl3 
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A3.7 Catalyst (84c): 
1
H NMR, 300 MHz, CDCl3 
 
 
13
C NMR, 300 MHz, CDCl3 
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A3.8 Catalyst (84d): 
1
H NMR, 300 MHz, CDCl3 
 
13
C NMR, 300 MHz, CDCl3 
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A3.9 (5R, 6R)-6-hydroxyhexadecanolide ((-)-20), chirality from (84b): 
1
H NMR, 300 MHz, CDCl3 
 
13
C NMR, 300 MHz, CDCl3 
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A3.10 (5R, 6R)-6-hydroxyhexadecanolide ((-)-20), chirality from (84c): 
1
H NMR, 300 MHz, CDCl3 
 
13
C NMR, 300 MHz, CDCl3 
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A3.11 (5R, 6R)-6-hydroxyhexadecanolide ((-)-20), chirality from (84d): 
1
H NMR, 300 MHz, CDCl3 
 
13
C NMR, 300 MHz, CDCl3 
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A3.12 (5R, 6R)-6-hydroxyhexadecanolide ((-)-20), chirality from L-proline: 
1
H NMR, 300 MHz, CDCl3 
 
13
C NMR, 300 MHz, CDCl3 
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A3.13 (5R, 6R)-6-(OBz)-hexadecanolide (95), chirality from (84d): 
1
H NMR, 300 MHz, CDCl3 
 
13
C NMR, 300 MHz, CDCl3 
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A3.14 (5R, 6R)-6-acetoxyhexadecanolide ((-)-2), chirality from (84d): 
1
H NMR, 300 MHz, CDCl3 
 
13
C NMR, 300 MHz, CDCl3 
 
  
0.51.01.52.02.53.03.54.04.55.0 ppm
0
.8
3
4
0
.8
5
7
0
.8
7
8
1
.2
3
2
1
.6
6
0
1
.8
1
6
2
.0
5
7
2
.0
7
7
2
.4
3
1
2
.4
5
4
2
.4
6
1
2
.5
5
7
2
.5
6
2
4
.3
1
3
4
.3
2
4
4
.3
3
6
4
.3
5
1
4
.3
6
2
4
.9
5
9
4
.9
7
2
2
.9
4
1
6
.0
0
3
.0
6
3
.0
8
0
.3
5
2
.4
8
2
.8
8
1
.0
2
1
.0
1
0
.9
8
0
.9
8
1D proton
1D proton
1D proton
1D proton
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
1
4
.0
8
1
8
.3
5
2
0
.9
3
2
2
.6
4
2
4
.0
6
2
5
.2
8
2
9
.2
6
2
9
.3
5
2
9
.4
1
2
9
.4
9
2
9
.5
2
2
9
.5
8
2
9
.8
7
3
1
.8
5
7
3
.8
3
7
9
.7
6
1
7
0
.6
0
1
7
0
.8
7
111 
 
A3.15 (5R, 6S)-6-acetoxyhexadecanolide ((-)-1), chirality from (84d): 
1
H NMR, 300 MHz, CDCl3 
 
13
C NMR, 300 MHz, CDCl3 
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A3.16 Shvo’s Catalyst (85): 
1
Hydride NMR, 300 MHz, CDCl3 
 
13
C NMR, 300 MHz, CDCl3 
 
  
-15-10-510 5 0 ppm
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A3.17 p-chlorophenyl acetate (100): 
1
H NMR, 300 MHz, CDCl3 
 
13
C NMR, 300 MHz, CDCl3 
 
 
  
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5 ppm
2
.2
9
7
7
.0
4
0
7
.0
6
9
7
.3
4
0
7
.3
6
9
3
.0
0
3
.8
4
1D proton
1D proton
1D proton
1D proton
102030405060708090100110120130140150160170180190 ppm
2
1
.0
0
1
2
2
.9
9
1
2
9
.4
5
1
3
1
.1
4
1
4
9
.1
8
1
6
9
.1
4
114 
 
A3.18 Epimerization of (()-20) to (()-10) using Shvo`s Catalyst (85): 
1
H NMR, 300 MHz, CDCl3 
 
13
C NMR, 300 MHz, CDCl3 
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A3.19 Product from attempted dynamic kinetic transformation of (()-20) using 
vinyl acetate donor (87): 
1
H NMR, 300 MHz, CDCl3 
 
13
C NMR, 300 MHz, CDCl3 
 
 
  
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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A3.20 Recovered starting material from attempted dynamic kinetic transformation 
of (()-20) using vinyl acetate donor (20 + 10): 
1
H NMR, 300 MHz, CDCl3 
 
13
C NMR, 300 MHz, CDCl3 
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A3.21 Product from attempted dynamic kinetic transformation of (()-20) using 
(100): 
1
H NMR, 300 MHz, CDCl3 
 
13
C NMR, 300 MHz, CDCl3 
 
  
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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A4.0 Raw Data for Metric Analysis 
A4.1 Dawson et al. Synthesis
9
 
Step 1: Aldol Reaction 
Reagent Mass (g) FW (g/mol) Carbons mol 
TiCl4 9.5 189.679 0 0.050 
1-TMS-l-
cyclopentene 
7.9 156.29 8 0.051 
undecanal 8.5 170.29 11 0.050 
Product 1 13.3 254.22 16 0.052 
Yield = not reported, E = 0.9, RME = 51 %, CE = 88 % 
Step 2: Key Oxidation Step 
Reagent Mass (g) FW (g/mol) Carbons mol 
Product 1 13.3 254.22 16 0.052 
m-CPBA 10 172.57 7 0.058 
KF 3 58.09 0 0.052 
Product 2 11.6 270.41 16 0.043 
Yield = 86 %, E = 1.3, RME = 44 %, CE = 55 % 
Step 3: Acetylation 
Reagent Mass (g) FW (g/mol) Carbons mol 
Product 2 5 270.41 16 0.018 
Ac2O 10 102.09 4 0.098 
pyridine 9.8 79.1 5 0.124 
Product 3 5.7 312.44 18 0.018 
Yield = 100 %, E = 3.4, RME = 23 %, CE = 25 % 
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A4.2 Michaelakis et al. Synthesis
12c
 
Step 1: Reduction of Valerolactone 
Reagent Mass (g) FW (g/mol) Carbons mol 
valerolactone 4.0 100.12 5 0.0400 
DIBAL-H  6.3 142.22 8 0.0440 
Product 1 3.6 102.13 5 0.0352 
Yield = 88 %, E = 1.8, RME = 35 %, CE = 32 % 
Step 2: Wittig Reaction 
Reagent Mass (g) FW (g/mol) Carbons mol 
Product 1 0.20 102.13 5 0.0020 
n-BuLi  0.19 64.06 4 0.0029 
Undecyltriphenylphosphonium 
bromide 
2.4 497.48 29 0.0048 
Product 2 0.42 240.42 16 0.0017 
Yield = 89 %, E = 5.6, RME = 15 %, CE = 17 % 
Step 3: Primary Alcohol Oxidation 
Reagent Mass (g) FW (g/mol) Carbons mol 
Product 2 0.42 240.42 16 0.0017 
K2Cr2O7 0.26 294.18 0 0.0009 
Product 3 0.35 254.41 16 0.0014 
Yield = 80 %, E = 1.0, RME = 51 %, CE = 79 % 
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Step 4: Key Oxidation Step 
Reagent Mass (g) FW (g/mol) Carbons mol 
Product 3 0.50 254.41 16 0.0020 
K3FeCN6 1.9 329.24 0 0.0059 
K2CO3 5.91 138.2 0 0.043 
K2OsO4 2H2O 0.0074 368.42 0 0.000020 
Product 4 0.52 288.42 16 0.0018 
Yield = 90 %, E = 15, RME = 6.2 %, CE = 92 % 
Step 5: Cyclization/Acetylation 
Reagent Mass (g) FW (g/mol) Carbons mol 
Product 4 0.10 288.42 16 0.00035 
pyridine 5.9 79.1 5 0.074 
Ac2O 1.3 102.09 4 0.012 
Product 5 0.087 312.44 18 0.00028 
Yield = 80 %, E = 83, RME = 1.2 %, CE = 1.2 % 
